<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69157</article-id><article-id pub-id-type="doi">10.7554/eLife.69157</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>The use of non-functional clonotypes as a natural calibrator for quantitative bias correction in adaptive immune receptor repertoire profiling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-233799"><name><surname>Smirnova</surname><given-names>Anastasia O</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233798"><name><surname>Miroshnichenkova</surname><given-names>Anna M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-233801"><name><surname>Olshanskaya</surname><given-names>Yulia V</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233802"><name><surname>Maschan</surname><given-names>Michael A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233803"><name><surname>Lebedev</surname><given-names>Yuri B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4554-4733</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233804"><name><surname>Chudakov</surname><given-names>Dmitriy M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0430-790X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233805"><name><surname>Mamedov</surname><given-names>Ilgar Z</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-233461"><name><surname>Komkov</surname><given-names>Alexander</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9113-698X</contrib-id><email>alexandrkomkov@yandex.ru</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03f9nc143</institution-id><institution>Skolkovo Institute of Science and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Moscow</named-content></addr-line><country>Russian Federation</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r493e52</institution-id><institution>Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry</institution></institution-wrap><addr-line><named-content content-type="city">Moscow</named-content></addr-line><country>Russian Federation</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02h8dsx08</institution-id><institution>Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology</institution></institution-wrap><addr-line><named-content content-type="city">Moscow</named-content></addr-line><country>Russian Federation</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/018159086</institution-id><institution>Pirogov Russian National Research Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Moscow</named-content></addr-line><country>Russian Federation</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02j46qs45</institution-id><institution>Central European Institute of Technology, Masaryk University</institution></institution-wrap><addr-line><named-content content-type="city">Brno</named-content></addr-line><country>Czech Republic</country></aff><aff id="aff6"><label>6</label><institution>Abu Dhabi Stem Cells Center</institution><addr-line><named-content content-type="city">Abu Dhabi</named-content></addr-line><country>United Arab Emirates</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rqy9422</institution-id><institution>University of Queensland</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taniguchi</surname><given-names>Tadatsugu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>University of Tokyo</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>01</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e69157</elocation-id><history><date date-type="received" iso-8601-date="2021-04-06"><day>06</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2023-01-22"><day>22</day><month>01</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-03-25"><day>25</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.03.24.436794"/></event></pub-history><permissions><copyright-statement>© 2023, Smirnova et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Smirnova et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69157-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69157-figures-v3.pdf"/><abstract><p>High-throughput sequencing of adaptive immune receptor repertoires is a valuable tool for receiving insights in adaptive immunity studies. Several powerful TCR/BCR repertoire reconstruction and analysis methods have been developed in the past decade. However, detecting and correcting the discrepancy between real and experimentally observed lymphocyte clone frequencies are still challenging. Here, we discovered a hallmark anomaly in the ratio between read count and clone count-based frequencies of non-functional clonotypes in multiplex PCR-based immune repertoires. Calculating this anomaly, we formulated a quantitative measure of V- and J-genes frequency bias driven by multiplex PCR during library preparation called Over Amplification Rate (OAR). Based on the OAR concept, we developed an original software for multiplex PCR-specific bias evaluation and correction named iROAR: immune Repertoire Over Amplification Removal (<ext-link ext-link-type="uri" xlink:href="https://github.com/smiranast/iROAR">https://github.com/smiranast/iROAR</ext-link>). The iROAR algorithm was successfully tested on previously published TCR repertoires obtained using both 5’ RACE (Rapid Amplification of cDNA Ends)-based and multiplex PCR-based approaches and compared with a biological spike-in-based method for PCR bias evaluation. The developed approach can increase the accuracy and consistency of repertoires reconstructed by different methods making them more applicable for comparative analysis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>immune receptor repertoire</kwd><kwd>high-throughput sequencing</kwd><kwd>multiplex PCR</kwd><kwd>PCR bias correction</kwd><kwd>adaptive immunity</kwd><kwd>TCR</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006769</institution-id><institution>Russian Science Foundation</institution></institution-wrap></funding-source><award-id>20-75-10091</award-id><principal-award-recipient><name><surname>Komkov</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002261</institution-id><institution>Russian Foundation for Basic Research</institution></institution-wrap></funding-source><award-id>20-015-00462</award-id><principal-award-recipient><name><surname>Komkov</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A hallmark property of non-functional clonotypes was used to develop a universal and fully computational method for detection and correction of multiplex PCR-specific quantitative bias in adaptive immune receptor repertoire.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Adaptive immune receptor (TCR – T-cell receptor and BCR – B-cell receptor) repertoire is usually defined as a set of TCR or BCR sequences obtained from an individual’s blood, bone marrow, or specific lymphocyte population. Reflecting the T/B cell’s clonal composition, the repertoire is characterized by a high degree of specificity for each individual and substantial variation in clone frequencies. The accuracy of both sequences and frequencies of TCR/BCR genes in the obtained repertoire is essential to receiving the correct biological information from immune repertoire analysis.</p><p>High-throughput sequencing (HTS) of adaptive immune receptor repertoires is widely used in immunological studies (reviewed in <xref ref-type="bibr" rid="bib18">Minervina et al., 2019</xref>) for the investigation of immune response to vaccines (<xref ref-type="bibr" rid="bib20">Minervina et al., 2021</xref>; <xref ref-type="bibr" rid="bib26">Pogorelyy et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Sycheva et al., 2022</xref>), tumor-infiltrating lymphocytes (<xref ref-type="bibr" rid="bib7">Gee et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Goncharov et al., 2022</xref>; <xref ref-type="bibr" rid="bib24">Oliveira et al., 2021</xref>), new therapeutic agents (<xref ref-type="bibr" rid="bib9">Huang et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Wilson et al., 2022</xref>), leukemia clonality, and minimal residual disease monitoring (<xref ref-type="bibr" rid="bib4">Brüggemann et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Komkov et al., 2020</xref>; <xref ref-type="bibr" rid="bib22">Nazarov et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Tirtakusuma et al., 2022</xref>; <xref ref-type="bibr" rid="bib36">Wood et al., 2018</xref>). HTS-based methods for immune repertoire profiling use either RNA or DNA as a starting material and, in most cases, use PCR for the selective enrichment of receptor sequences. DNA-based methods generally use two-sided multiplex PCR with primers annealing to multiple V- and J-genes of the rearranged receptor (<xref ref-type="bibr" rid="bib4">Brüggemann et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Komkov et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Robins et al., 2009</xref>). RNA-based methods start with cDNA synthesis, usually with TCR/BCR C(constant)-genes specific oligonucleotides, followed by one-side multiplex amplification with a set of V-gene specific primers and a universal C-gene specific primer (<xref ref-type="bibr" rid="bib32">Wang et al., 2010</xref>). Alternatively, two universal primers are used for amplification if an artificial sequence is added to the 5’ end during synthesis using a template-switch (5’-Rapid Amplification of cDNA Ends [RACE]; <xref ref-type="bibr" rid="bib16">Mamedov et al., 2013</xref>) or ligation (<xref ref-type="bibr" rid="bib23">Oakes et al., 2017</xref>). DNA-based methods protect the repertoire from gene transcription bias and provide more comprehensive results (<xref ref-type="bibr" rid="bib1">Barennes et al., 2020</xref>) which include most non-functional (out-of-frame) as well as functional (in-frame) rearrangements but produce high-amplification bias in the course of multiplex PCR. Additionally, each T/B cell contains a single DNA copy (i.e. two target strands) of the receptor molecule in contrast to tens of single-stranded RNA copies. RNA-based methods using 5’-RACE or ligation are characterized by the lowest PCR bias as they need a single primer pair for the amplification. However, the low efficiency of adding a universal oligo to the 5’ end makes its sensitivity comparable to or even lower than DNA-based methods. The compromise between these two approaches is the RNA-based method with a one-side multiplex that has moderate amplification bias yet sufficient sensitivity (<xref ref-type="bibr" rid="bib15">Ma et al., 2018</xref>). Most bias in one-side multiplex RNA-based approaches could be removed by using unique molecular identifiers (UMIs; <xref ref-type="bibr" rid="bib15">Ma et al., 2018</xref>). Unfortunately, for DNA-based methods, efficient incorporation of UMIs into the initial molecule before PCR is still challenging. The only method for DNA multiplex bias correction (<xref ref-type="bibr" rid="bib5">Carlson et al., 2013</xref>) is undirected and cost-ineffective due to the utilization of an expensive synthetic spike-in control repertoire. Here, we propose an orthogonal solution for this challenge: the first fully computational algorithm for amplification bias detection and correction in adaptive immune receptor repertoires named iROAR (immune Repertoire Over Amplification Removal).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The rationale for the Over Amplification Rate measure</title><p>Since out-of-frame TCR/BCR rearrangements do not form a functional receptor, they are not subjected to any specific clonal expansions and selection (<xref ref-type="bibr" rid="bib21">Murugan et al., 2012</xref>). Being a passenger genomic variation, they change their initial (recombinational) clonal frequencies just randomly following the frequency changes of the second functional (in-frame) TCR/BCR allele present in the same T/B cell clone. According to the TCR/BCR loci rearrangement mechanism, the formation of in-frame and out-of-frame allele combinations in the same cell is also a stochastic and independent process in terms of V- and J-genes frequency. It leads to the conclusion that V- and J-gene frequencies among out-of-frame rearrangements must be sufficiently stable and must be equal to the initial recombination frequencies despite repertoire changes caused by various immune challenges (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Thus, reproducible deviation of out-of-frame V- and J-gene frequencies (for the same multiplex PCR primer set) from the initial recombinational frequencies observed in the sequenced repertoire dataset is a result of artificial aberration caused by PCR amplification rather than immune repertoire evolution. Thus out-of-frame clonotypes can be considered a natural calibrator that can be used to measure amplification bias and quantitatively correct immune repertoire data.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Stability of TRBV and TRBJ genes frequencies calculated based on unique out-of-frame rearrangements after Yellow fever vaccination (model of acute viral infection).</title><p>Out-of-frame clonotypes for frequencies calculation were extracted from low-biased 5’ Rapid Amplification of cDNA Ends (RACE) TRB repertoires of PBMC (peripheral blood mononuclear cells) samples obtained in two replicates for six time points: 0, 5, 10, 15, 21, and 45 d after YFV (Yellow Fever Vaccine) injection (donor M1, SRA accession number PRJNA577794 <xref ref-type="bibr" rid="bib19">Minervina et al., 2020</xref>).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>XLSX table.</title><p>TRB V and J frequencies for plots in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig1-v3.tif"/></fig><p>Formulating this observation, we developed the Over Amplification Rate (OAR) measure, which we define as a ratio of the observed and expected frequency of a V- (OAR[Vi]) or a J-gene (OAR[Ji]) among identified out-of-frame rearrangements. Observed frequency represents a value calculated as read counts (RCs) for each V- and J-gene (related to out-of-frames) divided by the sum of all out-of-frame clones RC in the obtained repertoire sequencing dataset. The expected frequency is a value before amplification calculated as a number of unique out-of-frame clones (UCN) having each V- or J-gene divided by the total number of unique out-of-frame clones in the repertoire. At the final stage, each OAR is normalized by dividing by the average OAR.<disp-formula id="equ1"><mml:math id="m1"><mml:mi>O</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="bold-italic">V</mml:mi><mml:mi mathvariant="bold-italic">i</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:mfrac bevelled="true"><mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:mfrac bevelled="true"><mml:mrow><mml:mi>U</mml:mi><mml:mi>C</mml:mi><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi>U</mml:mi><mml:mi>C</mml:mi><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ2"><mml:math id="m2"><mml:mi>O</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="bold-italic">J</mml:mi><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:mfrac bevelled="true"><mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi><mml:mo>(</mml:mo><mml:mi>J</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi><mml:mo>(</mml:mo><mml:mi>J</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:mfrac bevelled="true"><mml:mrow><mml:mi>U</mml:mi><mml:mi>C</mml:mi><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mi>J</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi>U</mml:mi><mml:mi>C</mml:mi><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mi>J</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>OAR value tends to be equal to 1 under ideal conditions (low or no amplification bias). It deviates from 1 as amplification bias increases in line: 5’-RACE with a single universal primer pair, one-side multiplex PCR (VMPlex), and two-side multiplex PCR (VJMPlex; <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Dependence of the Over Amplification Rate on the TCR repertoire profiling method.</title><p>(<bold>a</bold>) Comparison of Over Amplification Rate (OAR) values variances for TRB repertoires obtained with 5’-Rapid Amplification of cDNA Ends (RACE), one-side multiplex (VMPlex), and two-side multiplex (VJMPlex) PCR. The Levene’s test was performed to compare OAR variances: ****p&lt;0.0001 and ***p&lt;0.001. The bar and whiskers indicate a mean and SD. (<bold>b</bold>) Average (bold lines) OAR values for TRBV and TRBJ genes in repertoires obtained with 5’-RACE, one-side multiplex (VMPlex), and two-side multiplex (VJMPlex) PCR. Pale lines illustrate OARs of individual repertoires. Datasets: six repertoires for RACE from PRJNA847436 (<xref ref-type="bibr" rid="bib30">Sycheva et al., 2022</xref>), six repertoires for VMPlex from PRJNA427746 (<xref ref-type="bibr" rid="bib15">Ma et al., 2018</xref>), and six repertoires for VJMPlex from 27483#.XpCuQ1MzZQI (<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/">zenodo.org</ext-link>; <xref ref-type="bibr" rid="bib34">Weinberger et al., 2015</xref>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>XLSX table.</title><p>Over Amplification Rate (OAR) values used for the plots in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Comparison of population V/J segment frequencies with individual frequencies obtained using different TCR repertoire profiling methods.</title><p>V- and J-gene frequencies among unique out-of-frame rearrangements calculated using biased (two-side multiplex, empty circles) and low-biased (Rapid Amplification of cDNA Ends [RACE], filled circles) are compared to average population frequencies (violin plot). Significantly biased V- and J-genes are highlighted pink. Paired (the same starting RNA samples) two-side multiplex and RACE data: SRA accession number PRJNA309577, population frequencies were calculated using a series of RACE TCR and single-cell TCRseq data (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig2-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-2"><title>The versatility of OAR measure</title><p>OAR measurement is a universal approach and can be applied to different types of immune repertoire data. To demonstrate this versatility, we calculated OAR values for low-biased (5’ RACE) repertoires of different adaptive immune receptor chains obtained from bulk human PBMC: TCR alpha (TRA), TCR beta (TRB), and BCR heavy chains (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). The results show that OARs for both TCR and BCR repertoires obtained by 5’ RACE are close to 1 and stay within the range of 0.5–2, which is much narrower than OAR for multiplex PCR-based repertoires (see main text <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Over Amplification Rate of low-biased TCR and BCR repertoires in different lymphocyte subsets.</title><p>(<bold>a</bold>) Distribution of Over Amplification Rates of V- and J-genes in Rapid Amplification of cDNA Ends (RACE)-based repertoires of TCR and BCR (the empty dots represent average OARs among TCR repertoires: SRA accession numbers: PRJNA577794, PRJNA316572, PRJEB27352, and BCR repertoires: SRA accession number: PRJNA297771 and PRJNA494572). (<bold>b</bold>) Over Amplification Rates of V- and J-genes of TCR alpha chains in RACE-based repertoires of different types of T-cells (donors M1 and P30, 45 d after booster vaccination, SRA accession number PRJNA577794; <xref ref-type="bibr" rid="bib19">Minervina et al., 2020</xref>). The bar and whiskers indicate a mean and SD.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>XLSX table.</title><p>Over Amplification Rate (OAR) values used for the plots in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig3-v3.tif"/></fig><p>We also analyzed OARs for low-biased (5’ RACE) TCR repertoires of different T cell subpopulations, including T-helper, cytotoxic, central memory, effector memory, and naïve T cells. As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, the OAR values demonstrate much less differences between analyzed T cell types then between RACE and multiplex PCR and are close enough to 1 similarly to the repertoire of bulk T cell mix obtained from PBMC.</p><p>Herewith, the variance of IGHV’s OARs compared TCRs’ and the variance of TCR subpopulations OARs compared PBMCs’ is slightly higher. This phenomenon may be linked to well-known differences in clonal expansion intensities of B/T-cell subsets which can affect indirectly the OAR values. However, the proof of this hypothesis demands separate deep analysis which is beyond the main focus of this research.</p><p>Despite it, our results demonstrate that OAR is a sufficiently universal measure of repertoires and can be applied to most adaptive immune receptors and cell types.</p></sec><sec id="s2-3"><title>Factors affecting OAR measure accuracy</title><p>In the case of insufficient sequencing coverage, high-PCR bias can lead to the dramatic loss of clones and thus an incorrect measurement of V- and J-genes frequencies. In this instance, for the majority of V- and J-genes, the population frequencies can approximate the real frequencies better than multiplex repertoire-based ones (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). If upon comparison samples’ UCN-based frequencies significantly differ from the average frequencies calculated for the population (i.e. exceeds 99% CI), OAR calculation should be based on the latter.</p><p>Also, the balance of V- and J-genes frequencies can be disrupted by accidentally arisen abnormally large non-functional clonotypes generated in the course of abnormal clonal expansion in various lymphoproliferative disorders or stochastic spike in normal lymphocyte population. To reduce the impact of this anomaly on OAR value, the top clone of each V- and J-gene containing subgroups must be excluded from OAR calculation. Since V- and J-specific bias affects all clones non-selectively, the remaining large part of clones after top clones exclusion should be still representative for PCR bias calculation. As shown in <xref ref-type="fig" rid="fig4">Figure 4a</xref>, the exclusion of one top clonotype from OAR calculation for RACE-based TRB repertoire is enough to restore OAR calculation accuracy for TRBV2, TRBV5-6, TRBV7-9, and TRBV11-3. The further top clones exclusion has no significant effect on OAR values.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Factors impacting Over Amplification Rate (OAR) calculation accuracy.</title><p>(<bold>a</bold>) Impact of highly proliferated top non-functional clonotype on OAR calculation accuracy in low-biased Rapid Amplification of cDNA Ends (RACE)-based TRB repertoire (Data: SRR19594184). (<bold>b</bold>) Impact of sequencing depth on OARs calculation error. (<bold>c</bold>) PCR bias independent changes of TRB V-genes OARs as a function of sequencing depth. Data: two-sided multiplex-based TRB repertoire (Data: RACE - SRR3129976, VJMPlex – SRR3129972).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>XLSX table.</title><p>Over Amplification Rate (OAR) values used for the plots in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig4-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig4-v3.tif"/></fig><p>Another aspect impacting the accuracy of OAR calculation is the low-sequencing coverage of the TCR/BCR repertoire. The ratio of total RCs and the sum of unique clone counts can affect OAR value despite PCR bias solely because of the mathematical properties of the OAR formula. In the extreme case, the OAR value (OAR = 1) for V- and J-genes represented in a single out-of-frame clone with only one read will not reflect the real amplification bias. To address this issue, we analyzed the OAR calculation error as a function of the number of reads per clone used for the OARs evaluation (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). For this purpose, we performed a serial down-sampling of TCR datasets generated by RACE and two-side multiplex PCR and calculated OAR measurement error for each dataset portion. OAR calculated for the entire dataset was taken as a benchmark. The result shows that 1.8 (for MPlex) and 2.5 (for RACE) reads per out-of-frame clonotype are a minimal sufficient sequencing coverage to get adequate OAR values with an acceptable error rate of ~10%.</p><p>It is also important to note that errors in nucleotide sequences occurring during library preparation and sequencing could lead to an artificial increase in both in-frame and out-of-frame clone diversity. Single nucleotide substitutions generate artificial clones as a branch of real most abundant clones inside of each in-frame and out-of-frame group independently. Single nucleotide indels lead to cross-generation artificial clones between groups: real in-frame clones generate false out-of-frame clones and vice versa. Artificial clones compromise the accuracy of both repertoire itself and OAR value. To eliminate such clones generated by single-nucleotide substitutions, we filtered them out by the VDJTOOLS software (see Methods section). To eliminate artificial clones produced by indels, we searched for in-frame and out-of-frame clone pairs which differ by one indel (Levenshtein distance = 1). If their ratio is less than 1:500, the smaller clone in pair is discarded, and its count is added to the count of the larger clone (this procedure guarantees to discard most sequencing errors present in 1 per 1000 nucleotides average).</p></sec><sec id="s2-4"><title>OAR-index</title><p>To estimate the value of immune repertoire structure disruption by amplification bias, we proposed the OAR-index, which represents the mean square deviation of OARs for each V- and J-gene from the value characteristic for repertoire with no bias (OAR = 1). OAR-index is directly proportional to the amplification bias and thus can be used for rapid estimation and comparison of immune repertoire bias. The less OAR-index is, the less PCR bias is with an ideally unbiased repertoire having OAR-index=0.<disp-formula id="equ3"><mml:math id="m3"><mml:mi>O</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mroot><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mi>O</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>i</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mroot></mml:math></disp-formula></p></sec><sec id="s2-5"><title>Using OAR for the removal of amplification bias</title><p>Normalization coefficients for each VJ combination are estimated by multiplication of corresponding V- and J-gene OARs for two-side multiplex and V-gene OAR for one-side multiplex (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). The corrected RC for each clonotype with the particular V-J gene combination is obtained simply by dividing the observed RC by the corresponding normalization coefficient. OAR of V- and J-genes could be co-dependent, which can be a reason for overcorrection. To avoid this issue, the procedure can be recursively repeated with a modified normalization coefficient defined as described coefficient raised to the power of a number in the range from 0 to 1 (parameter ‘mt’). The corrected RCs are used to estimate the real percentage of each clonotype in the repertoire. However, the all multiplex-based repertoires analyzed in actual study required just one iteration with mt = 1. A detailed flowchart of the OAR-based amplification bias correction algorithm named iROAR is shown in <xref ref-type="fig" rid="fig5">Figure 5a</xref>.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Implementation of OAR-based correction of quantitative bias in TCR repertoire.</title><p>(<bold>a</bold>) Flowchart of iROAR (immune Repertoire Over Amplification Removal) algorithm. UCF – Frequency calculated using unique clones counts (denominator of Over Amplification Rate [OAR]), pUCF – population UCF, RC – read count, RCn – normalized RC, RCo – observed RC, and mt – the number in the range from 0 to 1 for the iterative procedure. (<bold>b</bold>) Clone frequencies in the low biased 5’-Rapid Amplification of cDNA Ends (RACE)-based repertoire (ENA database, accession number ERR2869430) vs. the same repertoire with introduced artificial bias: before and after iROAR processing. (<bold>c</bold>) Out-of-frame (non-functional) clone frequencies in low biased 5’-RACE-based repertoire vs. two-side multiplex (VJMPlex)-based repertoire obtained for the same RNA sample (SRA database, accession numbers SRR3129976 and SRR3129972): before and after iROAR processing. (<bold>d</bold>) In-frame (functional) clone frequencies in low biased 5’-RACE-based repertoire vs. two-side multiplex (VJMPlex)-based repertoire obtained for the same RNA sample: before and after iROAR processing. SRA database, accession numbers SRR3129976 and SRR3129970. R<sup>2</sup> is the squared Pearson correlation coefficient. iROAR was applied only for biased repertoires: artificially biased RACE and VJMPlex. (<bold>e</bold>) OARV and OARJ of test 5’-RACE-based TRB repertoire (<bold>b</bold>) before artificial bias introduction (green dots and line), biased one (red dots and line) and corrected one by iROAR (blue dots and line).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>XLSX table.</title><p>Clonal frequencies used for the plots in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig5-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig5-v3.tif"/></fig></sec><sec id="s2-6"><title>OAR-based approach validation</title><p>The validation of OAR-based amplification bias correction was performed on the TRB dataset with in silico introduced bias generated from real (experimental) low-biased (5’-RACE) repertoire (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). After correction, the OAR-index indicating general repertoire bias expectedly decreased from 1.81 to 0.76. Interestingly, the OAR independent measure R<sup>2</sup> value of in silico biased and original repertoire correlation raised from 0.5350 to 0.8915, confirming the substantial reduction of in silico introduced quantitative bias. Afterward, we tested our approach on real paired experimental datasets obtained from the same RNA sample by two different method types: 5’-RACE and multiplex PCR (<xref ref-type="bibr" rid="bib1">Barennes et al., 2020</xref>; <xref ref-type="bibr" rid="bib14">Liu et al., 2016</xref>; <xref ref-type="fig" rid="fig5">Figure 5c–d</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Effect of iROAR (immune Repertoire Over Amplification Removal)-based PCR bias correction in MPlex repertoire on similarity with low-biased Rapid Amplification of cDNA Ends (RACE)-based repertoire obtained from the same RNA sample.</title><p>(<bold>a</bold>) Pearson correlation coefficient; (<bold>b</bold>) R<sup>2</sup> measure; (<bold>c</bold>) Morisita-Horn similarity index. **** p&lt;0.0001 (two-tailed Wilcoxon matched-pairs signed rank test, CI = 0.95). Dataset: PRJNA548335 three different RACE (RACE-2, RACE-3, and RACE-4 in six replicates each) protocols vs. RNA-based MPlex (Multiplex-3) protocol for Donor1 and Donor2 (100 ng RNA input): total 36 points; PRJNA309577 (one RACE protocol vs. one MPlex protocol) for Donors S01 (four MPlex replicates vs. two RACE replicates), S02 (two MPlex replicates vs. four RACE replicates), and donor S03 (one MPlex replicate vs. one RACE replicate): total 17 points.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>XLSX table.</title><p>Pearson R, R<sup>2</sup>, and Morisita-Horn index values used for the plots in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig6-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig6-v3.tif"/></fig><p>As a result of amplification bias correction, OAR-index for multiplex-based repertoire decreased 1.5-fold average. At the exact time, the correlation of clonal frequencies obtained with RACE and multiplex significantly increased (Pearson correlation measure and R<sup>2</sup> value increased 1.5-fold average each) with a significant rise of repertoires similarity (Morisita-Horn index increased 1.7-fold average; <xref ref-type="fig" rid="fig6">Figure 6</xref>). Importantly, amplification bias decreased in both out-of-frame and in-frame clone sets, although normalization coefficients were calculated using out-of-frame ones only.</p></sec><sec id="s2-7"><title>Comparison of iROAR and spike-in-based approach for amplification bias detection</title><p>Biological spike-in is considered a classical technique for multiplex PCR bias evaluation. Several options for this technique including synthetic repertoire (<xref ref-type="bibr" rid="bib5">Carlson et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Wu et al., 2020</xref>), lymphoid cell lines DNA mix, and DNA from human blood, tonsil, and thymus (<xref ref-type="bibr" rid="bib10">Kallemeijn et al., 2018</xref>; <xref ref-type="bibr" rid="bib11">Knecht et al., 2019</xref>) were established to measure V- and J-segment specific primers performance during TCR/BCR rearrangements amplification in multiplex PCR. In this study, we compared iROAR-based amplification bias evaluation with a spike-in-based approach. Similarly to <xref ref-type="bibr" rid="bib10">Kallemeijn et al., 2018</xref>; <xref ref-type="bibr" rid="bib11">Knecht et al., 2019</xref>, we were using natural thymic cell-derived spike-ins rather than synthetic ones. Human CD8 T-cells derived DNA was used as a target input for the libraries’ preparation. TRA rearrangements library of thymocytes were used as a source of spike-ins. Two different random mixes of TRAV- and TRAJ-specific primers (0.18–4.7 μM each) were used for multiplex PCR amplification of target DNA with spike-in added. Each test library was prepared in two replicas (four test libraries total). The obtained libraries were sequenced with an average coverage of 9.88 reads per clonotype and contained 35,818–40,209 target and 2298–3571 spike-in clonotypes after pseudogenes removal (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>The number of spike-in and target clonotypes in test TRA libraries.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Sample</th><th align="left" valign="bottom" colspan="3">Spike-in clonotypes</th><th align="left" valign="bottom" colspan="3">Target clonotypes</th></tr><tr><th align="left" valign="bottom">Number</th><th align="left" valign="bottom">Read count</th><th align="left" valign="bottom">Coverage</th><th align="left" valign="bottom">Number</th><th align="left" valign="bottom">Read count</th><th align="left" valign="bottom">Coverage</th></tr></thead><tbody><tr><td align="left" valign="bottom">Primer mix 1 Replica 1</td><td align="char" char="." valign="bottom">3571</td><td align="char" char="." valign="bottom">30,474</td><td align="char" char="." valign="bottom">8.53</td><td align="char" char="." valign="bottom">39,911</td><td align="char" char="." valign="bottom">348,792</td><td align="char" char="." valign="bottom">8.74</td></tr><tr><td align="left" valign="bottom">Primer mix 1 Replica 2</td><td align="char" char="." valign="bottom">2698</td><td align="char" char="." valign="bottom">19,420</td><td align="char" char="." valign="bottom">7.20</td><td align="char" char="." valign="bottom">35,818</td><td align="char" char="." valign="bottom">303,494</td><td align="char" char="." valign="bottom">8.47</td></tr><tr><td align="left" valign="bottom">Primer mix 2 Replica 1</td><td align="char" char="." valign="bottom">3439</td><td align="char" char="." valign="bottom">34,717</td><td align="char" char="." valign="bottom">10.10</td><td align="char" char="." valign="bottom">40,209</td><td align="char" char="." valign="bottom">425,508</td><td align="char" char="." valign="bottom">10.58</td></tr><tr><td align="left" valign="bottom">Primer mix 2 Replica 2</td><td align="char" char="." valign="bottom">2298</td><td align="char" char="." valign="bottom">24,823</td><td align="char" char="." valign="bottom">10.80</td><td align="char" char="." valign="bottom">33,406</td><td align="char" char="." valign="bottom">383,615</td><td align="char" char="." valign="bottom">11.48</td></tr></tbody></table></table-wrap><p>Multiplex PCR bias of each separate V- and J-gene was calculated using both iROAR and biological spike-in approaches demonstrating the high-correlation level (<xref ref-type="fig" rid="fig7">Figure 7a and b</xref>) for the matched OAR/spike-in pairs (Pearson’s <italic>r</italic>=0.78 average) in contrast to mismatched ones (Pearson’s <italic>r</italic>=0.46 average). VJ combination bias for both approaches was calculated by multiplying V- and J-segment biases and compared using correlation analysis (<xref ref-type="fig" rid="fig7">Figure 7c–e</xref>). iROAR and spike-in detected VJ biases showed a strong positive correlation (Pearson’s <italic>r</italic>=0.7182 average) for all four test TRA libraries (<xref ref-type="fig" rid="fig7">Figure 7c</xref>). Based on replicas comparison, the reproducibility of iROAR detected VJ bias was higher than one detected using spike-in control (<xref ref-type="fig" rid="fig7">Figure 7d and e</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Comparison of Over Amplification Rate (OAR)-based and biological spike-in-based approaches for multiplex PCR bias detection.</title><p>Pearson’s correlation coefficient for V-segments bias measure (<bold>a</bold>) and J-segments bias measure (<bold>b</bold>). Column and row titles: PM = Primer mix, <italic>R</italic>=replica. (<bold>c</bold>) Correlation of VJ combination bias calculated by iROAR (immune Repertoire Over Amplification Removal) and biological spike-ins. (<bold>d</bold>) Reproducibility of iROAR-based VJ combination bias detection. (<bold>e</bold>) Reproducibility of spike-in-based VJ combination bias detection. Data: PRJNA825832.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>XLSX table.</title><p>iROAR (immune Repertoire Over Amplification Removal)-based and spike-in-based PCR bias measures used for the plots in <xref ref-type="fig" rid="fig7">Figure 7</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig7-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig7-v3.tif"/></fig></sec><sec id="s2-8"><title>Impact of iROAR on a similarity of repertoires prepared by different multiplex PCR systems</title><p>To further test the iROAR approach’s ability to raise the uniformity of repertoires by reducing multiplex PCR-specific bias, we analyzed changes in the similarity of repertoires prepared for the same individual but using different multiplex methods. For this purpose, we compared OARs, V/J, and clonotype frequencies before and after bias correction using iROAR in test TRA libraries prepared with Primer mix 1 and Primer mix 2 (after spike-in removal). As a result of iROAR-based bias correction, the difference between OARs for these two library types significantly decreases, and OARs themselves approach a value of one. By default, iROAR does not affect the diversity of repertoires and does not remove any clonotypes. Meanwhile, V and J frequencies are subject to substantial changes (<xref ref-type="fig" rid="fig8">Figure 8b</xref>) depending on the initial bias level. These changes occur in both biased repertoires (Primer mix 1 and Primer mix 2) and lead to an increase its convergence (<xref ref-type="fig" rid="fig8">Figure 8d</xref>). Herewith, R<sup>2</sup> measure increased 1.31-fold and 1.5-fold for V- and J-gene frequencies, respectively. Moreover, bias correction using iROAR also increases similarities of clone frequencies (<xref ref-type="fig" rid="fig8">Figure 8c</xref>). In this case, both the Morisita-Horn index and Pearson correlation coefficient increase twofold and R<sup>2</sup> measure increases 1.5-fold.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Convergence of Over Amplification Rate (OAR), clonotype, and V/J frequencies between two TRA repertoire before and after iROAR (immune Repertoire Over Amplification Removal) based bias correction.</title><p>(<bold>a</bold>) OAR values changes in four test TRA libraries after PCR bias correction using iROAR. (<bold>b</bold>) TRAV and TRAJ frequency changes after PCR bias correction using iROAR (Sample: Primer mix 1 Replica 1). (<bold>c</bold>) Correlation of clonal frequencies of two different types of test TRA repertoires before and after iROAR-based PCR bias correction. (<bold>d</bold>) Correlation of V- and J-gene frequencies of test TRA repertoires before and after iROAR-based PCR bias correction.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>XLSX table.</title><p>Clonal frequencies, TRB V and J frequencies and Over Amplification Rate (OAR) values used for the plots in <xref ref-type="fig" rid="fig8">Figure 8</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-69157-fig8-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-69157-fig8-v3.tif"/></fig><p>It is important to note that OARs calculation and bias correction for each of the analyzed test TRA repertoires was performed entirely independently without the involvement of any common normalization coefficients or spike-in controls. Therefore, each repertoire contains enough information to correct it adequately, increasing the consistencies of interrogated repertoires obtained even by different multiplex PCR protocols.</p><p>All observed results can be considered evidence of the actual capacity of iROAR approach to accurately detect and reduce multiplex-specific quantitative bias in adaptive immune receptor repertoires.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Even a small difference in amplification efficiencies can lead to a massive bias after multiple amplification cycles due to the exponential nature of PCR. Thus, most of the existing immune repertoire library preparation methods are subjected to amplification bias. The effect of distinct PCR bias-generating factors can be reduced experimentally by varying reaction mixture content and introducing special protocols (UMI, crafty primer structures, and spike-in controls). However, the criteria for estimating and removing the residual bias after applying these optimization approaches are lacking. Here, we close this gap by introducing the OAR value and OAR-index, which score PCR bias for both V- and J-genes separately (OAR values) and the whole repertoire dataset (OAR-index). Based on OAR values, we developed the first fully computational approach to decipher and correct amplification bias in adaptive immune receptor repertoires produced by one- or two-side multiplex PCR-based methods, using RNA or DNA as a template. Due to the inability to use UMI-based correction for DNA-based multiplex, the developed approach is the only currently available technique allowing direct measuring and correcting PCR bias in such repertoires without additional experiments.</p><p>In contrast to cell-line mix spike-in (<xref ref-type="bibr" rid="bib11">Knecht et al., 2019</xref>) or synthetic repertoire-based (<xref ref-type="bibr" rid="bib5">Carlson et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Wu et al., 2020</xref>) PCR bias correction, the proposed approach operates with hundreds and even thousands of natural calibrators (out-of-frame clones) for each V-J gene pair. It makes this method potentially more reliable due to the ability to minimize the impact of CDR3 structure on PCR bias calculation since out-of-frame captures significantly higher CDR3 diversity than biological spike-ins. Moreover, similarly to a previously described method (<xref ref-type="bibr" rid="bib5">Carlson et al., 2013</xref>), the OAR-based approach can also be used for primer efficacy evaluation to optimize their structures and concentrations, which in turn will straighten the coverage of various V- and J-genes and minimize the number of experimentally lost clones. Being fully computational, the developed PCR bias correction algorithm can be easily implemented in any TCR/BCR repertoire analysis pipeline, noticeably improving the quantitative parts of the analysis. Even though it’s not possible to fully substitute the low-biased RACE methods, iROAR is capable to make multiplex-PCR-based repertoires more consistent with RACE-based ones. Therefore, the developed approach can provide the opportunity to compare the immune repertoire datasets generated using different library preparation methods.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Raw-data processing and immune repertoires reconstruction</title><p>All sequencing data used in this study represent human TCR and BCR repertoires. The repertoires (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) were reconstructed from fastq data using MiXCR v2 software (<xref ref-type="bibr" rid="bib3">Bolotin et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Bolotin et al., 2015</xref>) after primers and adapters trimming using FASTP software (<xref ref-type="bibr" rid="bib6">Chen et al., 2018</xref>). All obtained repertoires were converted to VDJTOOLS (<xref ref-type="bibr" rid="bib28">Shugay et al., 2015</xref>) format for unification. Erroneous clones generated by single nucleotide substitution were removed from the repertoire using the ‘Correct’ function from the VDJTOOLS software package. Erroneous clones generated by single nucleotide indels were removed from repertoires using the ‘Filter’ function from developed iROAR software. V and J pseudogenes were removed from repertoires using the ‘FilterBySegment’ function of VDJTOOLS.</p></sec><sec id="s4-2"><title>TRA repertoires preparation</title><p>The peripheral blood was collected from a healthy volunteer from the article’s co-authors with informed consent in a certified clinical lab. PBMC was separated from whole blood using the Ficoll-Paque approach. CD8+ T cells were isolated using Dynabeads CD8 Positive Isolation Kit (Invitrogen). DNA for library preparation was extracted from CD8+ T cells using FlexiGene DNA Kit (Qiagen). 150 ng aliquots of obtained DNA were used as input to prepare each out of four TRA libraries. Each DNA aliquot was premixed with 0.1 pg of serial diluted low-biased TRA library (prepared using MiLaboratories Human TCR kit) of thymic cells (spike-in matrix) as biological spike-ins. Two pools of previously designed (<xref ref-type="bibr" rid="bib12">Komkov et al., 2020</xref>) TRAV- and TRAJ-specific primers (MiLaboratories LLC) with randomly selected concentrations (0.18–4.7 μM each) were generated to produce two types of TRA libraries with different quantitative bias status simulating libraries produced by different multiplex PCR methods. Library preparation was performed according to the protocol from <xref ref-type="bibr" rid="bib12">Komkov et al., 2020</xref>. Both types of TRA libraries were prepared in two replicas and sequenced along with a spike-in matrix library on the MiSeq Illumina instrument (SE 150 nt) with moderate coverage 480,000 reads per library.</p></sec><sec id="s4-3"><title>Biological spike-in detection and analysis</title><p>TRA repertoires were extracted from FASTQ files using MIXCR software. All obtained MIXCR output files were converted to VDJTOOLS format as described above. Extraction of the spike-in sequences and spike-in-free repertoires from sequenced libraries was performed using the VDJTOOLS function ‘ApplySampleAsFilter’ and the sequenced spike-in library as a filter. Spike-in-based amplification bias was calculated as the quotient of V- and J-frequency in spike-ins extracted from target libraries and corresponding V- and J-frequency in the spike-in matrix, which was not subjected to multiplex amplification. OARs for obtained TRA libraries were calculated using iROAR software and spike-in-free repertoires as input. VJ bias values were calculated by multiplying V- to J-segment-specific biases. Correlation analysis of iROAR and spike-in VJ bias values was performed using GraphPad Prism9 software.</p></sec><sec id="s4-4"><title>Step-by-step pipeline for the OAR evaluation used in this study</title><list list-type="order"><list-item><p>Single nucleotide error correction in read1/read2 intersected sequences and Illumina adapters removal (optional): fastp -c -i input_R1.fastq.gz -I input_R2.fastq.gz -o fp.input_R1.fastq.gz -O fp.input_R2.fastq.gz.</p></list-item><list-item><p>Raw reads alignment (essential):</p><list list-type="alpha-lower"><list-item><p>For TCR beta chainsmixcr align -c TRB fp.input_R1.fastq.gz fp.input_R2.fastq.gz output1.vdjca.</p></list-item><list-item><p>For TCR beta chainsmixcr align -c TRA fp.input_R1.fastq.gz fp.input_R2.fastq.gz output1.vdjca.</p></list-item></list></list-item><list-item><p>Clonotypes assemble (essential): mixcr assemble output1.vdjca output2.clns</p></list-item><list-item><p>TCR repertoire export in a human-readable format (essential): mixcr export Clones output2.clns clones.txt.</p></list-item><list-item><p>Convert repertoire into VDJtools format (essential):java -jar vdjtools.jar Convert -S mixcr clones.txt vdjtools.</p></list-item><list-item><p>Artificial diversity removal by single nucleotide substitutions correction (optional):java -jar vdjtools.jar Correct vdjtools.clones.txt correct.</p></list-item><list-item><p>Pseudogenes removal (optional):</p><list list-type="alpha-lower"><list-item><p>For TCR beta chains.java -jar vdjtools.jar FilterBySegment –-j-segment TRBJ2-2P --v-segment TRBV1,TRBV12-1,TRBV12-2,TRBV17,TRBV21-1,TRBV22-1,TRBV23-1,TRBV26,TRBV5-2,TRBV5-3,TRBV5-7,TRBV6-7,TRBV7-1,TRBV7-5,TRBV8-1,TRBV8-2 --negative correct.vdjtools.clones.txt filter</p></list-item><list-item><p>For TCR alpha chainsjava -jar vdjtools.jar FilterBySegment -–j-segment TRAJ1,TRAJ19,TRAJ2,TRAJ25,TRAJ51,TRAJ55,TRAJ58,TRAJ59,TRAJ60,TRAJ61 --v-segment TRAV11,TRAV11-1,TRAV14-1,TRAV15,TRAV28,TRAV31,TRAV32,TRAV33,TRAV37,TRAV46,TRAV8-5,TRAV8-6-1,TRAV8-7 --negative correct.vdjtools.clones.txt filter</p></list-item></list></list-item><list-item><p>Artificial diversity removal by single nucleotide indels correction (optional):iroar Filter -se 0.01 filter.correct.vdjtools.clones.txt filter2.txt</p></list-item><list-item><p>OARs calculation and quantitative bias correction (essential):iroar Count -min_outframe 15 r -z 1 -iter 1 -mt 1 input_folder output_folder (input_folder must contain filter2.txt file).</p></list-item></list></sec><sec id="s4-5"><title>OAR evaluation and statistical analysis</title><p>For the OAR and OAR-index calculation and amplification bias removal, we used the command-line-based iROAR software designed in this study and freely available for non-profit use at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/smiranast/iROAR">https://github.com/smiranast/iROAR</ext-link>; <xref ref-type="bibr" rid="bib13">Komkov, 2023</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:6d7201302952a15597cfb50c2d4917c22efd966f;origin=https://github.com/smiranast/iROAR;visit=swh:1:snp:e92f096a8db6efcdc50263dba10a70e759b225f7;anchor=swh:1:rev:2362c4f41d40519154e1c2dc6ce7af619f15fb4b">swh:1:rev:2362c4f41d40519154e1c2dc6ce7af619f15fb4b</ext-link>). For the OAR comparison between 5’-RACE, one-side, and two-side multiplex PCRs, an equal number of out-of-frame clones (50,000) was randomly selected from TCR repertoires of 15 healthy individuals (for each approach). Average population V- and J-gene frequencies (unweighted) were calculated based on out-of-frame clones from 105 TRB repertoires obtained by two methods: 5’-RACE (95 repertoires) and single-cell TCR profiling (10× Genomics; 10 repertoires; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) using the ‘CalcSegmentUsage’ function with ‘-u’ parameter of VDJTOOLS. All statistical tests were performed using Prism9 GraphPad software (<ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>).</p></sec><sec id="s4-6"><title>iROAR software requirement</title><p>Recommended system configuration for iROAR running: Linux or MacOS, 2 CPU, 8 GB RAM, programming language: python = 3.7.3, required Python packages: matplotlib = 3.0.3, numpy = 1.16.2, pandas = 0.24.2, and requests = 2.21.0. Starting iROAR package includes list of average populational frequencies with SDs of TRB and TRA V- and J-genes related to the European population. iROAR run command: iroar Count (optional parameters) &lt;input&gt; &lt;output&gt;. Recommended parameters for most tasks: -min_outframe 15r -z 1 -iter 1 -mt 1. Full list of available parameters is deposited in project directory at github (<ext-link ext-link-type="uri" xlink:href="https://github.com/smiranast/iROAR">https://github.com/smiranast/iROAR</ext-link>).</p></sec><sec id="s4-7"><title>Data access</title><p>All analyzed datasets were downloaded from open-source databases: NCBI SRA (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra">https://www.ncbi.nlm.nih.gov/sra</ext-link>), ENA (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena">https://www.ebi.ac.uk/ena</ext-link>), and Zenodo project (<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/">https://zenodo.org/</ext-link>). A complete list of web links and accession numbers is summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. TRA repertoire dataset generated in this study for iROAR validation is available under access number PRJNA825832.</p><p>The iROAR software and its documentation are available at the link: <ext-link ext-link-type="uri" xlink:href="https://github.com/smiranast/iROAR">https://github.com/smiranast/iROAR</ext-link>. The additional software used in this study is available in the GitHub repository: MiXCR v2 (<xref ref-type="bibr" rid="bib2">Bolotin et al., 2015</xref>) (<ext-link ext-link-type="uri" xlink:href="https://github.com/milaboratory/mixcr">https://github.com/milaboratory/mixcr</ext-link>; <xref ref-type="bibr" rid="bib17">MiLaboratories, 2023</xref>), VDJTOOLS (<xref ref-type="bibr" rid="bib28">Shugay et al., 2015</xref>) ( <ext-link ext-link-type="uri" xlink:href="https://github.com/mikessh/vdjtools">https://github.com/mikessh/vdjtools</ext-link>; <xref ref-type="bibr" rid="bib29">Shugay, 2022</xref>), and FASTP (<xref ref-type="bibr" rid="bib6">Chen et al., 2018</xref>) (<ext-link ext-link-type="uri" xlink:href="https://github.com/OpenGene/fastp">https://github.com/OpenGene/fastp</ext-link>; <xref ref-type="bibr" rid="bib25">OpenGene - Open Source Genomics Toolbox, 2022</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con2"><p>Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>XLSX table.</title><p>Dataset accession numbers and references to the original studies generated it.</p></caption><media xlink:href="elife-69157-supp1-v3.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>XLSX table.</title><p>Comparison of iROAR (immune Repertoire Over Amplification Removal) algorithm with the existing approaches for PCR bias removal in human adaptive immune receptor repertoires.</p></caption><media xlink:href="elife-69157-supp2-v3.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-69157-transrepform1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in SRA under accession code PRJNA825832. All other sequencing data analyzed during this study are previously published and fully available under links or access numbers included in the manuscript and supporting files.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Smirnova</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>TRA repertoire</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA825832/">PRJNA825832</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>RL</given-names></name><name><surname>Freeman</surname><given-names>JD</given-names></name><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Choe</surname><given-names>G</given-names></name><name><surname>Munro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes</data-title><source>NCBI Sequence Read Archive</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRA020989">SRA020989</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Zvyagin</surname><given-names>IV</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Homo sapiens T-cell repertoire - MZ twins</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA214848">PRJNA214848</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Rosati</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>TCR repertoire in IBD twins</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB27352">PRJEB27352</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>de Greef</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>TCR repertoire sequencing of T cell subsets from healthy individuals</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA390125">PRJNA390125</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Pogorelyy</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Precise tracking of vaccine-responding T-cell clones reveals convergent and personalized response in identical twins</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA493983">PRJNA493983</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><collab>Turchaninova et al</collab></person-group><year iso-8601-date="2016">2016</year><data-title>Protocol for full length profiling of IG repertoires</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA297771">PRJNA297771</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset8"><person-group person-group-type="author"><collab>Minervina et al</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Comprehensive analysis of antiviral adaptive immunity formation and reactivation down to single cell level</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA577794">PRJNA577794</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset9"><person-group person-group-type="author"><collab>Simon et al</collab></person-group><year iso-8601-date="2018">2018</year><data-title>Sequencing the Peripheral Blood B and T cell Repertoire - Quantifying robustness and limitations</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA494572">PRJNA494572</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset10"><person-group person-group-type="author"><collab>Pan et al</collab></person-group><year iso-8601-date="2019">2019</year><data-title>Identification of drug-specific public TCR driving severe cutaneous adverse reactions</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA550004">PRJNA550004</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset11"><person-group person-group-type="author"><collab>Ma et al</collab></person-group><year iso-8601-date="2018">2018</year><data-title>Homo sapiens Raw sequence reads</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA427746">PRJNA427746</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset12"><person-group person-group-type="author"><collab>Truong et al</collab></person-group><year iso-8601-date="2019">2019</year><data-title>TCR diversity and clonality of human CD4+ memory T cells</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB31283">PRJEB31283</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset13"><person-group person-group-type="author"><collab>Simnica et al</collab></person-group><year iso-8601-date="2019">2019</year><data-title>Immunoaging</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB33490">PRJEB33490</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset14"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>J</given-names></name><name><surname>Jimenez-Heredia</surname><given-names>R</given-names></name><name><surname>Schaller</surname><given-names>S</given-names></name><name><surname>Suessner</surname><given-names>S</given-names></name><name><surname>Sunzenauer</surname><given-names>J</given-names></name><name><surname>Reindl-Schwaighofer</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Winkler</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>C</given-names></name><name><surname>Danzer</surname><given-names>M</given-names></name><name><surname>Oberbauer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Immune repertoire profiling reveals that clonally expanded B and T cells infiltrating diseased human kidneys can also be tracked in the blood</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.27483</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset15"><person-group person-group-type="author"><collab>Tanno et al</collab></person-group><year iso-8601-date="2019">2019</year><data-title>Paired TCR alpha:TCR beta sequencing at the single-cell level</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA593622">PRJNA593622</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset16"><person-group person-group-type="author"><collab>Liu et al</collab></person-group><year iso-8601-date="2016">2016</year><data-title>TRB and IGH are captured from peripheral blood using Multiplex PCR and 5'RACE</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA309577">PRJNA309577</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset17"><person-group person-group-type="author"><name><surname>Barennes</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA548335">PRJNA548335</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Grigory Armeev and Valery Novoseletsky for their help with data storage and processing. This work was supported by Russian Science Foundation (grant 20-75-10091 to A.K.), the analysis of TRA MPlex data was supported by Russian Foundation for Basic Research (grant 20-015-00462 to A.K.).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barennes</surname><given-names>P</given-names></name><name><surname>Quiniou</surname><given-names>V</given-names></name><name><surname>Shugay</surname><given-names>M</given-names></name><name><surname>Egorov</surname><given-names>ES</given-names></name><name><surname>Davydov</surname><given-names>AN</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Uddin</surname><given-names>I</given-names></name><name><surname>Ismail</surname><given-names>M</given-names></name><name><surname>Oakes</surname><given-names>T</given-names></name><name><surname>Chain</surname><given-names>B</given-names></name><name><surname>Eugster</surname><given-names>A</given-names></name><name><surname>Kashofer</surname><given-names>K</given-names></name><name><surname>Rainer</surname><given-names>PP</given-names></name><name><surname>Darko</surname><given-names>S</given-names></name><name><surname>Ransier</surname><given-names>A</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Klatzmann</surname><given-names>D</given-names></name><name><surname>Mariotti-Ferrandiz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases</article-title><source>Nature Biotechnology</source><volume>39</volume><fpage>236</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0656-3</pub-id><pub-id pub-id-type="pmid">32895550</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolotin</surname><given-names>DA</given-names></name><name><surname>Poslavsky</surname><given-names>S</given-names></name><name><surname>Mitrophanov</surname><given-names>I</given-names></name><name><surname>Shugay</surname><given-names>M</given-names></name><name><surname>Mamedov</surname><given-names>IZ</given-names></name><name><surname>Putintseva</surname><given-names>EV</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MiXCR: software for comprehensive adaptive immunity profiling</article-title><source>Nature Methods</source><volume>12</volume><fpage>380</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3364</pub-id><pub-id pub-id-type="pmid">25924071</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolotin</surname><given-names>DA</given-names></name><name><surname>Poslavsky</surname><given-names>S</given-names></name><name><surname>Davydov</surname><given-names>AN</given-names></name><name><surname>Frenkel</surname><given-names>FE</given-names></name><name><surname>Fanchi</surname><given-names>L</given-names></name><name><surname>Zolotareva</surname><given-names>OI</given-names></name><name><surname>Hemmers</surname><given-names>S</given-names></name><name><surname>Putintseva</surname><given-names>EV</given-names></name><name><surname>Obraztsova</surname><given-names>AS</given-names></name><name><surname>Shugay</surname><given-names>M</given-names></name><name><surname>Ataullakhanov</surname><given-names>RI</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name><name><surname>Schumacher</surname><given-names>TN</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Antigen receptor repertoire profiling from RNA-Seq data</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>908</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1038/nbt.3979</pub-id><pub-id pub-id-type="pmid">29020005</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brüggemann</surname><given-names>M</given-names></name><name><surname>Kotrová</surname><given-names>M</given-names></name><name><surname>Knecht</surname><given-names>H</given-names></name><name><surname>Bartram</surname><given-names>J</given-names></name><name><surname>Boudjogrha</surname><given-names>M</given-names></name><name><surname>Bystry</surname><given-names>V</given-names></name><name><surname>Fazio</surname><given-names>G</given-names></name><name><surname>Froňková</surname><given-names>E</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name><name><surname>Grioni</surname><given-names>A</given-names></name><name><surname>Hancock</surname><given-names>J</given-names></name><name><surname>Herrmann</surname><given-names>D</given-names></name><name><surname>Jiménez</surname><given-names>C</given-names></name><name><surname>Krejci</surname><given-names>A</given-names></name><name><surname>Moppett</surname><given-names>J</given-names></name><name><surname>Reigl</surname><given-names>T</given-names></name><name><surname>Salson</surname><given-names>M</given-names></name><name><surname>Scheijen</surname><given-names>B</given-names></name><name><surname>Schwarz</surname><given-names>M</given-names></name><name><surname>Songia</surname><given-names>S</given-names></name><name><surname>Svaton</surname><given-names>M</given-names></name><name><surname>van Dongen</surname><given-names>JJM</given-names></name><name><surname>Villarese</surname><given-names>P</given-names></name><name><surname>Wakeman</surname><given-names>S</given-names></name><name><surname>Wright</surname><given-names>G</given-names></name><name><surname>Cazzaniga</surname><given-names>G</given-names></name><name><surname>Davi</surname><given-names>F</given-names></name><name><surname>García-Sanz</surname><given-names>R</given-names></name><name><surname>Gonzalez</surname><given-names>D</given-names></name><name><surname>Groenen</surname><given-names>PJTA</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Macintyre</surname><given-names>EA</given-names></name><name><surname>Stamatopoulos</surname><given-names>K</given-names></name><name><surname>Pott</surname><given-names>C</given-names></name><name><surname>Trka</surname><given-names>J</given-names></name><name><surname>Darzentas</surname><given-names>N</given-names></name><name><surname>Langerak</surname><given-names>AW</given-names></name><collab>EuroClonality-NGS working group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a euroclonality-NGS validation study</article-title><source>Leukemia</source><volume>33</volume><fpage>2241</fpage><lpage>2253</lpage><pub-id pub-id-type="doi">10.1038/s41375-019-0496-7</pub-id><pub-id pub-id-type="pmid">31243313</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>CS</given-names></name><name><surname>Emerson</surname><given-names>RO</given-names></name><name><surname>Sherwood</surname><given-names>AM</given-names></name><name><surname>Desmarais</surname><given-names>C</given-names></name><name><surname>Chung</surname><given-names>MW</given-names></name><name><surname>Parsons</surname><given-names>JM</given-names></name><name><surname>Steen</surname><given-names>MS</given-names></name><name><surname>LaMadrid-Herrmannsfeldt</surname><given-names>MA</given-names></name><name><surname>Williamson</surname><given-names>DW</given-names></name><name><surname>Livingston</surname><given-names>RJ</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Wood</surname><given-names>BL</given-names></name><name><surname>Rieder</surname><given-names>MJ</given-names></name><name><surname>Robins</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Using synthetic templates to design an unbiased multiplex PCR assay</article-title><source>Nature Communications</source><volume>4</volume><elocation-id>2680</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms3680</pub-id><pub-id pub-id-type="pmid">24157944</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><volume>34</volume><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname><given-names>MH</given-names></name><name><surname>Han</surname><given-names>A</given-names></name><name><surname>Lofgren</surname><given-names>SM</given-names></name><name><surname>Beausang</surname><given-names>JF</given-names></name><name><surname>Mendoza</surname><given-names>JL</given-names></name><name><surname>Birnbaum</surname><given-names>ME</given-names></name><name><surname>Bethune</surname><given-names>MT</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Gomez-Eerland</surname><given-names>R</given-names></name><name><surname>Bingham</surname><given-names>DB</given-names></name><name><surname>Sibener</surname><given-names>LV</given-names></name><name><surname>Fernandes</surname><given-names>RA</given-names></name><name><surname>Velasco</surname><given-names>A</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name><name><surname>Schumacher</surname><given-names>TN</given-names></name><name><surname>Khatri</surname><given-names>P</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Garcia</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes</article-title><source>Cell</source><volume>172</volume><fpage>549</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.043</pub-id><pub-id pub-id-type="pmid">29275860</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncharov</surname><given-names>MM</given-names></name><name><surname>Bryushkova</surname><given-names>EA</given-names></name><name><surname>Sharaev</surname><given-names>NI</given-names></name><name><surname>Skatova</surname><given-names>VD</given-names></name><name><surname>Baryshnikova</surname><given-names>AM</given-names></name><name><surname>Sharonov</surname><given-names>GV</given-names></name><name><surname>Karnaukhov</surname><given-names>V</given-names></name><name><surname>Vakhitova</surname><given-names>MT</given-names></name><name><surname>Samoylenko</surname><given-names>IV</given-names></name><name><surname>Demidov</surname><given-names>LV</given-names></name><name><surname>Lukyanov</surname><given-names>S</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Serebrovskaya</surname><given-names>EO</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pinpointing the tumor-specific T cells via TCR clusters</article-title><source>eLife</source><volume>11</volume><elocation-id>e77274</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.77274</pub-id><pub-id pub-id-type="pmid">35377314</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Alexey</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>T</given-names></name><name><surname>Grande</surname><given-names>G</given-names></name><name><surname>Douthit</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Michael</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>XL</given-names></name><name><surname>Fu</surname><given-names>G</given-names></name><name><surname>Alexander</surname><given-names>G</given-names></name><name><surname>Tzeng</surname><given-names>C-M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies</article-title><source>Leukemia</source><volume>33</volume><fpage>2315</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.1038/s41375-019-0455-3</pub-id><pub-id pub-id-type="pmid">30962578</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallemeijn</surname><given-names>MJ</given-names></name><name><surname>Kavelaars</surname><given-names>FG</given-names></name><name><surname>van der Klift</surname><given-names>MY</given-names></name><name><surname>Wolvers-Tettero</surname><given-names>ILM</given-names></name><name><surname>Valk</surname><given-names>PJM</given-names></name><name><surname>van Dongen</surname><given-names>JJM</given-names></name><name><surname>Langerak</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Next-generation sequencing analysis of the human TCRγδ+ T-cell repertoire reveals shifts in Vγ- and Vδ-usage in memory populations upon aging</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>448</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00448</pub-id><pub-id pub-id-type="pmid">29559980</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knecht</surname><given-names>H</given-names></name><name><surname>Reigl</surname><given-names>T</given-names></name><name><surname>Kotrová</surname><given-names>M</given-names></name><name><surname>Appelt</surname><given-names>F</given-names></name><name><surname>Stewart</surname><given-names>P</given-names></name><name><surname>Bystry</surname><given-names>V</given-names></name><name><surname>Krejci</surname><given-names>A</given-names></name><name><surname>Grioni</surname><given-names>A</given-names></name><name><surname>Pal</surname><given-names>K</given-names></name><name><surname>Stranska</surname><given-names>K</given-names></name><name><surname>Plevova</surname><given-names>K</given-names></name><name><surname>Rijntjes</surname><given-names>J</given-names></name><name><surname>Songia</surname><given-names>S</given-names></name><name><surname>Svatoň</surname><given-names>M</given-names></name><name><surname>Froňková</surname><given-names>E</given-names></name><name><surname>Bartram</surname><given-names>J</given-names></name><name><surname>Scheijen</surname><given-names>B</given-names></name><name><surname>Herrmann</surname><given-names>D</given-names></name><name><surname>García-Sanz</surname><given-names>R</given-names></name><name><surname>Hancock</surname><given-names>J</given-names></name><name><surname>Moppett</surname><given-names>J</given-names></name><name><surname>van Dongen</surname><given-names>JJM</given-names></name><name><surname>Cazzaniga</surname><given-names>G</given-names></name><name><surname>Davi</surname><given-names>F</given-names></name><name><surname>Groenen</surname><given-names>PJTA</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Macintyre</surname><given-names>EA</given-names></name><name><surname>Stamatopoulos</surname><given-names>K</given-names></name><name><surname>Trka</surname><given-names>J</given-names></name><name><surname>Langerak</surname><given-names>AW</given-names></name><name><surname>Gonzalez</surname><given-names>D</given-names></name><name><surname>Pott</surname><given-names>C</given-names></name><name><surname>Brüggemann</surname><given-names>M</given-names></name><name><surname>Darzentas</surname><given-names>N</given-names></name><collab>EuroClonality-NGS Working Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by euroclonality-NGS</article-title><source>Leukemia</source><volume>33</volume><fpage>2254</fpage><lpage>2265</lpage><pub-id pub-id-type="doi">10.1038/s41375-019-0499-4</pub-id><pub-id pub-id-type="pmid">31227779</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komkov</surname><given-names>A</given-names></name><name><surname>Miroshnichenkova</surname><given-names>A</given-names></name><name><surname>Nugmanov</surname><given-names>G</given-names></name><name><surname>Popov</surname><given-names>A</given-names></name><name><surname>Pogorelyy</surname><given-names>M</given-names></name><name><surname>Zapletalova</surname><given-names>E</given-names></name><name><surname>Jelinkova</surname><given-names>H</given-names></name><name><surname>Pospisilova</surname><given-names>S</given-names></name><name><surname>Lebedev</surname><given-names>Y</given-names></name><name><surname>Chudakov</surname><given-names>D</given-names></name><name><surname>Olshanskaya</surname><given-names>Y</given-names></name><name><surname>Plevova</surname><given-names>K</given-names></name><name><surname>Maschan</surname><given-names>M</given-names></name><name><surname>Mamedov</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>High-Throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies</article-title><source>British Journal of Haematology</source><volume>188</volume><fpage>723</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1111/bjh.16230</pub-id><pub-id pub-id-type="pmid">31587259</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Komkov</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>IROAR</data-title><version designator="swh:1:rev:2362c4f41d40519154e1c2dc6ce7af619f15fb4b">swh:1:rev:2362c4f41d40519154e1c2dc6ce7af619f15fb4b</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:6d7201302952a15597cfb50c2d4917c22efd966f;origin=https://github.com/smiranast/iROAR;visit=swh:1:snp:e92f096a8db6efcdc50263dba10a70e759b225f7;anchor=swh:1:rev:2362c4f41d40519154e1c2dc6ce7af619f15fb4b">https://archive.softwareheritage.org/swh:1:dir:6d7201302952a15597cfb50c2d4917c22efd966f;origin=https://github.com/smiranast/iROAR;visit=swh:1:snp:e92f096a8db6efcdc50263dba10a70e759b225f7;anchor=swh:1:rev:2362c4f41d40519154e1c2dc6ce7af619f15fb4b</ext-link></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Nie</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Kristiansen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Systematic comparative evaluation of methods for investigating the TCRβ repertoire</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0152464</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0152464</pub-id><pub-id pub-id-type="pmid">27019362</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>KY</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Wendel</surname><given-names>BS</given-names></name><name><surname>Williams</surname><given-names>CM</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immune repertoire sequencing using molecular identifiers enables accurate clonality discovery and clone size quantification</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00033</pub-id><pub-id pub-id-type="pmid">29467754</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamedov</surname><given-names>IZ</given-names></name><name><surname>Britanova</surname><given-names>OV</given-names></name><name><surname>Zvyagin</surname><given-names>IV</given-names></name><name><surname>Turchaninova</surname><given-names>MA</given-names></name><name><surname>Bolotin</surname><given-names>DA</given-names></name><name><surname>Putintseva</surname><given-names>EV</given-names></name><name><surname>Lebedev</surname><given-names>YB</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Preparing unbiased T-cell receptor and antibody cdna libraries for the deep next generation sequencing profiling</article-title><source>Frontiers in Immunology</source><volume>4</volume><elocation-id>456</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2013.00456</pub-id><pub-id pub-id-type="pmid">24391640</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="software"><person-group person-group-type="author"><collab>MiLaboratories</collab></person-group><year iso-8601-date="2023">2023</year><data-title>Mixcr</data-title><version designator="a2a8ed8">a2a8ed8</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/milaboratory/mixcr">https://github.com/milaboratory/mixcr</ext-link></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minervina</surname><given-names>A</given-names></name><name><surname>Pogorelyy</surname><given-names>M</given-names></name><name><surname>Mamedov</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>T-Cell receptor and B-cell receptor repertoire profiling in adaptive immunity</article-title><source>Transplant International</source><volume>32</volume><fpage>1111</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1111/tri.13475</pub-id><pub-id pub-id-type="pmid">31250479</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minervina</surname><given-names>AA</given-names></name><name><surname>Pogorelyy</surname><given-names>MV</given-names></name><name><surname>Komech</surname><given-names>EA</given-names></name><name><surname>Karnaukhov</surname><given-names>VK</given-names></name><name><surname>Bacher</surname><given-names>P</given-names></name><name><surname>Rosati</surname><given-names>E</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Mamedov</surname><given-names>IZ</given-names></name><name><surname>Lebedev</surname><given-names>YB</given-names></name><name><surname>Mora</surname><given-names>T</given-names></name><name><surname>Walczak</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones</article-title><source>eLife</source><volume>9</volume><elocation-id>e53704</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53704</pub-id><pub-id pub-id-type="pmid">32081129</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minervina</surname><given-names>AA</given-names></name><name><surname>Komech</surname><given-names>EA</given-names></name><name><surname>Titov</surname><given-names>A</given-names></name><name><surname>Bensouda Koraichi</surname><given-names>M</given-names></name><name><surname>Rosati</surname><given-names>E</given-names></name><name><surname>Mamedov</surname><given-names>IZ</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Efimov</surname><given-names>GA</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Mora</surname><given-names>T</given-names></name><name><surname>Walczak</surname><given-names>AM</given-names></name><name><surname>Lebedev</surname><given-names>YB</given-names></name><name><surname>Pogorelyy</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection</article-title><source>eLife</source><volume>10</volume><elocation-id>e63502</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.63502</pub-id><pub-id pub-id-type="pmid">33399535</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murugan</surname><given-names>A</given-names></name><name><surname>Mora</surname><given-names>T</given-names></name><name><surname>Walczak</surname><given-names>AM</given-names></name><name><surname>Callan</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Statistical inference of the generation probability of T-cell receptors from sequence repertoires</article-title><source>PNAS</source><volume>109</volume><fpage>16161</fpage><lpage>16166</lpage><pub-id pub-id-type="doi">10.1073/pnas.1212755109</pub-id><pub-id pub-id-type="pmid">22988065</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarov</surname><given-names>VI</given-names></name><name><surname>Minervina</surname><given-names>AA</given-names></name><name><surname>Komkov</surname><given-names>AY</given-names></name><name><surname>Pogorelyy</surname><given-names>MV</given-names></name><name><surname>Maschan</surname><given-names>MA</given-names></name><name><surname>Olshanskaya</surname><given-names>YV</given-names></name><name><surname>Zvyagin</surname><given-names>IV</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Lebedev</surname><given-names>YB</given-names></name><name><surname>Mamedov</surname><given-names>IZ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Reliability of immune receptor rearrangements as genetic markers for minimal residual disease monitoring</article-title><source>Bone Marrow Transplantation</source><volume>51</volume><fpage>1408</fpage><lpage>1410</lpage><pub-id pub-id-type="doi">10.1038/bmt.2016.148</pub-id><pub-id pub-id-type="pmid">27214078</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakes</surname><given-names>T</given-names></name><name><surname>Heather</surname><given-names>JM</given-names></name><name><surname>Best</surname><given-names>K</given-names></name><name><surname>Byng-Maddick</surname><given-names>R</given-names></name><name><surname>Husovsky</surname><given-names>C</given-names></name><name><surname>Ismail</surname><given-names>M</given-names></name><name><surname>Joshi</surname><given-names>K</given-names></name><name><surname>Maxwell</surname><given-names>G</given-names></name><name><surname>Noursadeghi</surname><given-names>M</given-names></name><name><surname>Riddell</surname><given-names>N</given-names></name><name><surname>Ruehl</surname><given-names>T</given-names></name><name><surname>Turner</surname><given-names>CT</given-names></name><name><surname>Uddin</surname><given-names>I</given-names></name><name><surname>Chain</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Quantitative characterization of the T cell receptor repertoire of naïve and memory subsets using an integrated experimental and computational pipeline which is robust, economical, and versatile</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>1267</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01267</pub-id><pub-id pub-id-type="pmid">29075258</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>G</given-names></name><name><surname>Stromhaug</surname><given-names>K</given-names></name><name><surname>Klaeger</surname><given-names>S</given-names></name><name><surname>Kula</surname><given-names>T</given-names></name><name><surname>Frederick</surname><given-names>DT</given-names></name><name><surname>Le</surname><given-names>PM</given-names></name><name><surname>Forman</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Cieri</surname><given-names>N</given-names></name><name><surname>Clauser</surname><given-names>KR</given-names></name><name><surname>Shukla</surname><given-names>SA</given-names></name><name><surname>Neuberg</surname><given-names>D</given-names></name><name><surname>Justesen</surname><given-names>S</given-names></name><name><surname>MacBeath</surname><given-names>G</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Fritsch</surname><given-names>EF</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Sade-Feldman</surname><given-names>M</given-names></name><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Boland</surname><given-names>GM</given-names></name><name><surname>Ott</surname><given-names>PA</given-names></name><name><surname>Keskin</surname><given-names>DB</given-names></name><name><surname>Wu</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma</article-title><source>Nature</source><volume>596</volume><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03704-y</pub-id><pub-id pub-id-type="pmid">34290406</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="software"><person-group person-group-type="author"><collab>OpenGene - Open Source Genomics Toolbox</collab></person-group><year iso-8601-date="2022">2022</year><data-title>Fastp</data-title><version designator="1bc2c53">1bc2c53</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/OpenGene/fastp">https://github.com/OpenGene/fastp</ext-link></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogorelyy</surname><given-names>MV</given-names></name><name><surname>Minervina</surname><given-names>AA</given-names></name><name><surname>Touzel</surname><given-names>MP</given-names></name><name><surname>Sycheva</surname><given-names>AL</given-names></name><name><surname>Komech</surname><given-names>EA</given-names></name><name><surname>Kovalenko</surname><given-names>EI</given-names></name><name><surname>Karganova</surname><given-names>GG</given-names></name><name><surname>Egorov</surname><given-names>ES</given-names></name><name><surname>Komkov</surname><given-names>AY</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Mamedov</surname><given-names>IZ</given-names></name><name><surname>Mora</surname><given-names>T</given-names></name><name><surname>Walczak</surname><given-names>AM</given-names></name><name><surname>Lebedev</surname><given-names>YB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Precise tracking of vaccine-responding T cell clones reveals convergent and personalized response in identical twins</article-title><source>PNAS</source><volume>115</volume><fpage>12704</fpage><lpage>12709</lpage><pub-id pub-id-type="doi">10.1073/pnas.1809642115</pub-id><pub-id pub-id-type="pmid">30459272</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robins</surname><given-names>HS</given-names></name><name><surname>Campregher</surname><given-names>PV</given-names></name><name><surname>Srivastava</surname><given-names>SK</given-names></name><name><surname>Wacher</surname><given-names>A</given-names></name><name><surname>Turtle</surname><given-names>CJ</given-names></name><name><surname>Kahsai</surname><given-names>O</given-names></name><name><surname>Riddell</surname><given-names>SR</given-names></name><name><surname>Warren</surname><given-names>EH</given-names></name><name><surname>Carlson</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells</article-title><source>Blood</source><volume>114</volume><fpage>4099</fpage><lpage>4107</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-04-217604</pub-id><pub-id pub-id-type="pmid">19706884</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shugay</surname><given-names>M</given-names></name><name><surname>Bagaev</surname><given-names>DV</given-names></name><name><surname>Turchaninova</surname><given-names>MA</given-names></name><name><surname>Bolotin</surname><given-names>DA</given-names></name><name><surname>Britanova</surname><given-names>OV</given-names></name><name><surname>Putintseva</surname><given-names>EV</given-names></name><name><surname>Pogorelyy</surname><given-names>MV</given-names></name><name><surname>Nazarov</surname><given-names>VI</given-names></name><name><surname>Zvyagin</surname><given-names>IV</given-names></name><name><surname>Kirgizova</surname><given-names>VI</given-names></name><name><surname>Kirgizov</surname><given-names>KI</given-names></name><name><surname>Skorobogatova</surname><given-names>EV</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>VDJtools: unifying post-analysis of T cell receptor repertoires</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004503</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004503</pub-id><pub-id pub-id-type="pmid">26606115</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Shugay</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Vdjtools</data-title><version designator="1655b10">1655b10</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/mikessh/vdjtools">https://github.com/mikessh/vdjtools</ext-link></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sycheva</surname><given-names>AL</given-names></name><name><surname>Komech</surname><given-names>EA</given-names></name><name><surname>Pogorelyy</surname><given-names>MV</given-names></name><name><surname>Minervina</surname><given-names>AA</given-names></name><name><surname>Urazbakhtin</surname><given-names>SZ</given-names></name><name><surname>Salnikova</surname><given-names>MA</given-names></name><name><surname>Vorovitch</surname><given-names>MF</given-names></name><name><surname>Kopantzev</surname><given-names>EP</given-names></name><name><surname>Zvyagin</surname><given-names>IV</given-names></name><name><surname>Komkov</surname><given-names>AY</given-names></name><name><surname>Mamedov</surname><given-names>IZ</given-names></name><name><surname>Lebedev</surname><given-names>YB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inactivated tick-borne encephalitis vaccine elicits several overlapping waves of T cell response</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>970285</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.970285</pub-id><pub-id pub-id-type="pmid">36091004</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tirtakusuma</surname><given-names>R</given-names></name><name><surname>Szoltysek</surname><given-names>K</given-names></name><name><surname>Milne</surname><given-names>P</given-names></name><name><surname>Grinev</surname><given-names>VV</given-names></name><name><surname>Ptasinska</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>PS</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Nakjang</surname><given-names>S</given-names></name><name><surname>Hehir-Kwa</surname><given-names>JY</given-names></name><name><surname>Williamson</surname><given-names>D</given-names></name><name><surname>Cauchy</surname><given-names>P</given-names></name><name><surname>Keane</surname><given-names>P</given-names></name><name><surname>Assi</surname><given-names>SA</given-names></name><name><surname>Ashtiani</surname><given-names>M</given-names></name><name><surname>Kellaway</surname><given-names>SG</given-names></name><name><surname>Imperato</surname><given-names>MR</given-names></name><name><surname>Vogiatzi</surname><given-names>F</given-names></name><name><surname>Schweighart</surname><given-names>EK</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Wunderlich</surname><given-names>M</given-names></name><name><surname>Stutterheim</surname><given-names>J</given-names></name><name><surname>Komkov</surname><given-names>A</given-names></name><name><surname>Zerkalenkova</surname><given-names>E</given-names></name><name><surname>Evans</surname><given-names>P</given-names></name><name><surname>McNeill</surname><given-names>H</given-names></name><name><surname>Elder</surname><given-names>A</given-names></name><name><surname>Martinez-Soria</surname><given-names>N</given-names></name><name><surname>Fordham</surname><given-names>SE</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Russell</surname><given-names>LJ</given-names></name><name><surname>Pal</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Kingsbury</surname><given-names>Z</given-names></name><name><surname>Becq</surname><given-names>J</given-names></name><name><surname>Eckert</surname><given-names>C</given-names></name><name><surname>Haas</surname><given-names>OA</given-names></name><name><surname>Carey</surname><given-names>P</given-names></name><name><surname>Bailey</surname><given-names>S</given-names></name><name><surname>Skinner</surname><given-names>R</given-names></name><name><surname>Miakova</surname><given-names>N</given-names></name><name><surname>Collin</surname><given-names>M</given-names></name><name><surname>Bigley</surname><given-names>V</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>Marschalek</surname><given-names>R</given-names></name><name><surname>Harrison</surname><given-names>CJ</given-names></name><name><surname>Cargo</surname><given-names>CA</given-names></name><name><surname>Schewe</surname><given-names>D</given-names></name><name><surname>Olshanskaya</surname><given-names>Y</given-names></name><name><surname>Thirman</surname><given-names>MJ</given-names></name><name><surname>Cockerill</surname><given-names>PN</given-names></name><name><surname>Mulloy</surname><given-names>JC</given-names></name><name><surname>Blair</surname><given-names>HJ</given-names></name><name><surname>Vormoor</surname><given-names>J</given-names></name><name><surname>Allan</surname><given-names>JM</given-names></name><name><surname>Bonifer</surname><given-names>C</given-names></name><name><surname>Heidenreich</surname><given-names>O</given-names></name><name><surname>Bomken</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia</article-title><source>Blood</source><volume>140</volume><fpage>1875</fpage><lpage>1890</lpage><pub-id pub-id-type="doi">10.1182/blood.2021015036</pub-id><pub-id pub-id-type="pmid">35839448</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Sanders</surname><given-names>CM</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Schroeder</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Babrzadeh</surname><given-names>F</given-names></name><name><surname>Gharizadeh</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Hudson</surname><given-names>JR</given-names></name><name><surname>Davis</surname><given-names>RW</given-names></name><name><surname>Han</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets</article-title><source>PNAS</source><volume>107</volume><fpage>1518</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1073/pnas.0913939107</pub-id><pub-id pub-id-type="pmid">20080641</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>DeKosky</surname><given-names>BJ</given-names></name><name><surname>Timm</surname><given-names>MR</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Normandin</surname><given-names>E</given-names></name><name><surname>Misasi</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>R</given-names></name><name><surname>McDaniel</surname><given-names>JR</given-names></name><name><surname>Delidakis</surname><given-names>G</given-names></name><name><surname>Leigh</surname><given-names>KE</given-names></name><name><surname>Niezold</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>CW</given-names></name><name><surname>Viox</surname><given-names>EG</given-names></name><name><surname>Fahad</surname><given-names>A</given-names></name><name><surname>Cagigi</surname><given-names>A</given-names></name><name><surname>Ploquin</surname><given-names>A</given-names></name><name><surname>Leung</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>ES</given-names></name><name><surname>Kong</surname><given-names>W-P</given-names></name><name><surname>Voss</surname><given-names>WN</given-names></name><name><surname>Schmidt</surname><given-names>AG</given-names></name><name><surname>Moody</surname><given-names>MA</given-names></name><name><surname>Ambrozak</surname><given-names>DR</given-names></name><name><surname>Henry</surname><given-names>AR</given-names></name><name><surname>Laboune</surname><given-names>F</given-names></name><name><surname>Ledgerwood</surname><given-names>JE</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name><name><surname>Connors</surname><given-names>M</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Sullivan</surname><given-names>NJ</given-names></name><name><surname>Ellington</surname><given-names>AD</given-names></name><name><surname>Mascola</surname><given-names>JR</given-names></name><name><surname>Georgiou</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional interrogation and mining of natively paired human VH: VL antibody repertoires</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>152</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/nbt.4052</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>J</given-names></name><name><surname>Jimenez-Heredia</surname><given-names>R</given-names></name><name><surname>Schaller</surname><given-names>S</given-names></name><name><surname>Suessner</surname><given-names>S</given-names></name><name><surname>Sunzenauer</surname><given-names>J</given-names></name><name><surname>Reindl-Schwaighofer</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Winkler</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>C</given-names></name><name><surname>Danzer</surname><given-names>M</given-names></name><name><surname>Oberbauer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune repertoire profiling reveals that clonally expanded B and T cells infiltrating diseased human kidneys can also be tracked in blood</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0143125</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0143125</pub-id><pub-id pub-id-type="pmid">26600245</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>TL</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Chou</surname><given-names>C-H</given-names></name><name><surname>Langfitt</surname><given-names>D</given-names></name><name><surname>Mettelman</surname><given-names>RC</given-names></name><name><surname>Minervina</surname><given-names>AA</given-names></name><name><surname>Allen</surname><given-names>EK</given-names></name><name><surname>Métais</surname><given-names>J-Y</given-names></name><name><surname>Pogorelyy</surname><given-names>MV</given-names></name><name><surname>Riberdy</surname><given-names>JM</given-names></name><name><surname>Velasquez</surname><given-names>MP</given-names></name><name><surname>Kottapalli</surname><given-names>P</given-names></name><name><surname>Trivedi</surname><given-names>S</given-names></name><name><surname>Olsen</surname><given-names>SR</given-names></name><name><surname>Lockey</surname><given-names>T</given-names></name><name><surname>Willis</surname><given-names>C</given-names></name><name><surname>Meagher</surname><given-names>MM</given-names></name><name><surname>Triplett</surname><given-names>BM</given-names></name><name><surname>Talleur</surname><given-names>AC</given-names></name><name><surname>Gottschalk</surname><given-names>S</given-names></name><name><surname>Crawford</surname><given-names>JC</given-names></name><name><surname>Thomas</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T-cell receptor lineages</article-title><source>Cancer Discovery</source><volume>12</volume><fpage>2098</fpage><lpage>2119</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-21-1508</pub-id><pub-id pub-id-type="pmid">35792801</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Crossley</surname><given-names>B</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Williamson</surname><given-names>D</given-names></name><name><surname>Gawad</surname><given-names>C</given-names></name><name><surname>Borowitz</surname><given-names>MJ</given-names></name><name><surname>Devidas</surname><given-names>M</given-names></name><name><surname>Maloney</surname><given-names>KW</given-names></name><name><surname>Larsen</surname><given-names>E</given-names></name><name><surname>Winick</surname><given-names>N</given-names></name><name><surname>Raetz</surname><given-names>E</given-names></name><name><surname>Carroll</surname><given-names>WL</given-names></name><name><surname>Hunger</surname><given-names>SP</given-names></name><name><surname>Loh</surname><given-names>ML</given-names></name><name><surname>Robins</surname><given-names>H</given-names></name><name><surname>Kirsch</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL</article-title><source>Blood</source><volume>131</volume><fpage>1350</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-09-806521</pub-id><pub-id pub-id-type="pmid">29284596</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Mai</surname><given-names>H</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Developing an unbiased multiplex PCR system to enrich the TRB repertoire toward accurate detection in leukemia</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>1631</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01631</pub-id><pub-id pub-id-type="pmid">32849555</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69157.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rqy9422</institution-id><institution>University of Queensland</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.03.24.436794" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.24.436794"/></front-stub><body><p>This paper describes a newly developed, publicly available algorithm (iROAR) that was tested on pre-exisiting datasets and is of interest to T and B cell immunologists who perform repertoire analysis via multiplex PCR based techniques. iROAR utilises naturally occurring non-functional sequences to improve and partially correct the amplification bias inherent in multiplex PCR based sequencing technologies.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69157.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rqy9422</institution-id><institution>University of Queensland</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Cowell</surname><given-names>Lindsay</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.24.436794">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.03.24.436794v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The use of non-functional clonotypes as a natural spike-in for multiplex PCR bias correction in immune receptor repertoire profiling&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Tadatsugu Taniguchi as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Lindsay Cowell (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The reviewers are enthusiastic about this manuscript. They have identified a number of issues that require clarification and are generally thought to be important to reach the broad immunology audience.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The conclusions are mostly well supported. However, there are some concerns that should be addressed before this paper is accepted for publication.</p><p>The authors have kindly provided the iROAR software free for non-profit use on Github. As this entire study was performed to validate and share this software to other scientists, I would suggest that the iROAR documentation be improved such that it can be used by a wide audience. More detailed instructions for use and perhaps even a step by step example on how to replicate the results in this study included in the documentation would be very helpful.</p><p>The authors utilised pre-existing datasets that performed both multiplex PCR (high bias) and 5'-RACE (low bias) on the same sample to test the functionality of iROAR. The iROAR algorithm improved the PCR bias in repertoires that were obtained by multiplex PCR which better correlated with the same repertoire determined by 5'-RACE. It is important to note that although the iROAR algorithm improved PCR bias, it is by no means perfect and cannot substitute for a low bias approach. Even for a 5'-RACE repertoire in which artificial bias was introduced in silico, iROAR improved the correlation of the in silico biased 5'-RACE from R2 = 0.4052 to R2 = 0.6286 which is an improvement but certainly cannot substitute for a repertoire that was determined using a low bias approach.</p><p>The authors very nicely showed the extent of amplification bias when using multiplex PCR based technologies by plotting the OAR distributions in Figure 2A and Figure 2B. It would be very informative to plot the iROAR corrected OAR and OAR distributions as well in order to visualise the improvement in bias correction in the same way..</p><p>The authors state that an F-test was performed to compare OAR distributions in Figure 2A. Please state exactly which F-test was used to calculate statistical significance.</p><p>The authors state that they use a z-test to exclude outliers from the OAR calculation that may have resulted from large clonotypes introduced by PCR bias or naturally generated from clonal expansions. The authors should describe further how this affects analysis of repertoires in which large clonal expansions are expected such as during an antiviral immune response.</p><p>The authors nicely compared clonal frequency between iROAR corrected and 5'-RACE repertoires in Figure 4B-D. I think it would also be important to know how the iROAR algorithm would affect other measurements commonly used when analysing TCR/BCR repertoires. For example, does iROAR also affect measurements of diversity? This would be especially useful when comparing corrected repertoires vs. 5'-RACE.</p><p>As per <italic>eLife</italic> policy, &quot;Regardless of whether authors use original data or are reusing data available from public repositories, they must provide program code, scripts for statistical packages, and other documentation sufficient to allow an informed researcher to precisely reproduce all published results.&quot; I would recommend that the authors very much improve the documentation provided in the Github repository for iROAR such that anyone can reproduce the published results before publication. Additionally, <italic>eLife</italic> suggests that the authors should license their code using an open source license.</p><p>Line 158: What do you mean by z-test? Can you explain under which circumstances you can decide to exclude abnormally large clonotypes? How has this threshold been calculated? Would this negatively affect measurements of OAR during an immune response such as viral infections where large clonotypes might be observed?</p><p>Line 167, 2.5 reads is a minimal sufficient sequencing coverage. Does the package provide this quality control check? This would be useful information that could be included in the manuscript as well as within iROAR documentation.</p><p>Line 203 Figure 4: Can the authors also generate the OAR distributions (a per Figure 2B) for these datasets before and after iROAR? Would be very useful as a comparison between 5' RACE and other multiplex PCR methods as well as to assess the efficacy of iROAR in correcting bias.</p><p>Line 219, How does the in silico introduced bias look with regards to the OAR? Can you generate the OAR distributions of in silico biased and unbiased samples using the same graphing method in Figure2B?</p><p>The Discussion section needs much more discussion on its applications as well as limitations. Ie., how does the software deal with instances where clonal expansions occur in cell clones that are also bearing a non-functional receptor? How does this affect the OAR calculation?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Enthusiasm is dampened by the fact that the proposed method is not directly compared to the gold standard of biological spike-ins. The results would be stronger if the authors could use data generated with a biological spike-in and compare correction using data from the spike-in versus their proposed algorithm. If such a data set is publicly available or can be obtained by request, this should be done. If such a data set cannot be obtained, then the Discussion section should directly address the fact that this gold standard validation remains to be done.</p><p>Figure 2:</p><p>– More interpretation of the results is needed in the Discussion. For example, Figure 2a appears to show that for VMPlex and VJMPlex, most genes suffer from under- rather than over-amplification. This seems unexpected. I would have expected &quot;zero-sum-game&quot; behavior. Also, it is surprising that VJMPlex shows less overall bias than VMPlex. Does this make sense? Why or why not? I think a plot like Figure 1 is needed for VMPlex and VJMPlex to ensure that the base assumption underlying OAR calculation holds in the same way and to the same degree across the three technologies.</p><p>– Regarding the input data: &quot;for each method type 15 PBMC TCR repertoires were chosen randomly from&quot; and this is followed by a list of 11 study/project identifiers. More information is needed. Fifteen seems like a small number, but it depends on the details. How do the 11 studies distribute across the three methods? How many studies were included in each method? Were 15 repertoires total used for each method? Or 15 from each study? Did the different studies within a method use the same primer set? The same depth coverage?</p><p>– How much within-study between-repertoire variability is there for a single V or J gene? And how much variability is there across studies? It seems important to understand this basic behavior of the metric before pooling into a single figure, as the pooling can average out important behavior.</p><p>Figure 3: More interpretation of the results is needed.</p><p>– In Figure 3a, the range of values is greater for TRBV and IGHV. Could this be attributed to a larger number of genes or primers, or to more sequence variability (and presumably therefore greater variability in primer hybridization efficiency)?</p><p>– In Figure 3b, while there may be no difference in the mean or median OAR value across cell types, there does appear to be a difference in the range, with PBMCs and THs showing much less variability than the other cell types. What could explain this? Is this an artifact of the way samples were pooled for the figure? Are both donors represented in all six cell types? Or does this point to some interesting biology? If the latter, then exploration of this is understandably beyond the scope of this paper, but it should be mentioned and possible explanations should be put forward.</p><p>Lines 197 – &quot;the procedure can be recursively repeated with a modified normalization coefficient defined as described coefficient raised to the power of a number in the range from 0 to 1.&quot;: How is the value of this number determined? This sounds like an optimization procedure, in which case much more information is needed. In particular: what algorithm was used? what is the objective function? What are the stopping criteria? In which of the presented results was this procedure applied?</p><p>Line 87 &quot;constant during a lifetime&quot;: this needs to be substantiated with either a reference or data. The authors show relevant data in Supplementary Figure 1, but there is no description of how the data shown in the figure were derived. For example: are all data points from a single study? do all data points used in a single regression (i.e., all those corresponding to the same gene segment) derive from the same patient? do all data in the figure derive from one single patient? what sequencing protocol was used? Has the proposed correction been applied? The strength of the claim should reflect the strength of the data. Note: I don't think the truth of this claim is a requirement for the proposed method to be valid. So if the data are such that the statement cannot be generalized to &quot;all&quot; repertoires, I don't see this as a problem.</p><p>Line 89 &quot;reproducible&quot;: reproducible in what way? Over multiple aliquots of a sample? Over multiple samples for the same person? Over multiple people?</p><p>Figure 1: Is the same stability observed for the sequencing protocols with even more amplification bias (VMPlex and VJMPlex)?</p><p>Lines 102 – 109: this paragraph is not clearly written, but it is the heart of the manuscript. The paragraph reads as if only the two terms with summations are based on out-of-frame rearrangements. I assume all four terms are based on out-of-frame rearrangements? Because otherwise the equation does not make sense …. Also, I recommend removing &quot;a percentage of&quot; in line 105, as this reads as if there is a percentage in the numerator of the numerator (i.e., the RC(Vi) term). Finally, in line 107, I assume you mean PCR amplification instead of clonal expansion?</p><p>Figure 2: More information about the data is needed. Specific details are below.</p><p>Lines 149 – 153 starting with &quot;the average population frequencies&quot;: It isn't clear what is meant by &quot;average population frequencies&quot;, and it isn't clear what the rest of the paragraph implies about calculations described in the paper and results displayed in the figures. It sounds as if different repertoires may have been subjected to different calculations.</p><p>Lines 157 – 158: The last sentence of this paragraph suggests that V- or J-genes with large or small relative frequencies may have been excluded. More details are needed. Were only large clones excluded? How were they identified for exclusion? By what method and what exclusion threshold was used? How many were excluded from each repertoire? If more than &quot;a few&quot;, then before and after data need to be shown for some repertoires to show how this impacts the OAR distributions and averages.</p><p>Lines 167 – 169: how is &quot;adequate&quot; defined? Within the 10% error range discussed in the context of Supplemental Figure 3?</p><p>Lines 257 – 262: These sentences suggest that the proposed approach is more reliable than biological spike-ins. This should be substantiated before being claimed. The authors state that this is because &quot;the impact of CDR3 structure&quot; is minimized. Why is this? Because the number of out-of-frame rearrangements is much much larger than the number of cell-line or synthetic spike-ins and so captures more CDR3 diversity? Or some other reason? More explanation of why this is being suggested should be given and the wording should make clear that this is an untested hypothesis.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69157.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The conclusions are mostly well supported. However, there are some concerns that should be addressed before this paper is accepted for publication.</p><p>The authors have kindly provided the iROAR software free for non-profit use on Github. As this entire study was performed to validate and share this software to other scientists, I would suggest that the iROAR documentation be improved such that it can be used by a wide audience. More detailed instructions for use and perhaps even a step by step example on how to replicate the results in this study included in the documentation would be very helpful.</p></disp-quote><p>We edited the documentation at GitHub and provided step-by-step instructions for the general usage in the Methods section “Step-by-step pipeline for the OAR evaluation used in this study”:</p><list list-type="bullet"><list-item><p>Single nucleotide error correction in read1/read2 intersected sequences and Illumina adapters removal (optional):</p></list-item></list><p>fastp -c -i input_R1.fastq.gz -I input_R2.fastq.gz -o fp.input_R1.fastq.gz -O fp.input_R2.fastq.gz</p><list list-type="bullet"><list-item><p>Raw reads alignment (essential):</p></list-item></list><list list-type="bullet"><list-item><p>For TCR β chains</p></list-item></list><p>mixcr align -c TRB fp.input_R1.fastq.gz fp.input_R2.fastq.gz output1.vdjca</p><list list-type="bullet"><list-item><p>For TCR β chains</p></list-item></list><p>mixcr align -c TRA fp.input_R1.fastq.gz fp.input_R2.fastq.gz output1.vdjca</p><list list-type="bullet"><list-item><p>Clonotypes assemble (essential):</p></list-item></list><p>mixcr assemble output1.vdjca output2.clns</p><list list-type="bullet"><list-item><p>TCR repertoire export in a human-readable format (essential):</p></list-item></list><p>mixcr exportClones output2.clns clones.txt</p><list list-type="bullet"><list-item><p>Convert repertoire into VDJtools format (essential):</p></list-item></list><p>java -jar vdjtools.jar Convert -S mixcr clones.txt vdjtools</p><list list-type="bullet"><list-item><p>Artificial diversity removal by single nucleotide substitutions correction (optional):</p></list-item></list><p>java -jar vdjtools.jar Correct vdjtools.clones.txt correct</p><list list-type="bullet"><list-item><p>Pseudogenes removal (optional):</p></list-item></list><list list-type="bullet"><list-item><p>For TCR β chains</p></list-item></list><p>java -jar vdjtools.jar FilterBySegment –-j-segment TRBJ2-2P --v-segment TRBV1,TRBV12-1,TRBV12-2,TRBV17,TRBV21-1,TRBV22-1,TRBV23-1,TRBV26,TRBV5-2,TRBV5-3,TRBV5-7,TRBV6-7,TRBV7-1,TRBV7-5,TRBV8-1,TRBV8-2 –-negative correct.vdjtools.clones.txt filter</p><list list-type="bullet"><list-item><p>For TCR α chains</p></list-item></list><p>java -jar vdjtools.jar FilterBySegment -–j-segment TRAJ1,TRAJ19,TRAJ2,TRAJ25,TRAJ51,TRAJ55,TRAJ58,TRAJ59,TRAJ60,TRAJ61 --v-segment TRAV11,TRAV11-1,TRAV14-1,TRAV15,TRAV28,TRAV31,TRAV32,TRAV33,TRAV37,TRAV46,TRAV8-5,TRAV8-6-1,TRAV8-7 –-negative correct.vdjtools.clones.txt filter</p><list list-type="bullet"><list-item><p>Artificial diversity removal by single nucleotide indels correction (optional):</p></list-item></list><p>iroar Filter -se 0.01 filter.correct.vdjtools.clones.txt filter2.txt</p><list list-type="bullet"><list-item><p>OARs calculation and quantitative bias correction (essential):</p></list-item></list><p>iroar Count -min_outframe 15 -z 1 -mt 1 -iter 1 input_folder output_folder</p><disp-quote content-type="editor-comment"><p>(input_folder must contain filter2.txt file)</p><p>The authors utilised pre-existing datasets that performed both multiplex PCR (high bias) and 5'-RACE (low bias) on the same sample to test the functionality of iROAR. The iROAR algorithm improved the PCR bias in repertoires that were obtained by multiplex PCR which better correlated with the same repertoire determined by 5'-RACE. It is important to note that although the iROAR algorithm improved PCR bias, it is by no means perfect and cannot substitute for a low bias approach. Even for a 5'-RACE repertoire in which artificial bias was introduced in silico, iROAR improved the correlation of the in silico biased 5'-RACE from R2 = 0.4052 to R2 = 0.6286 which is an improvement but certainly cannot substitute for a repertoire that was determined using a low bias approach.</p></disp-quote><p>We added a suggested sentence: “Even though it’s not possible to fully substitute the low-biased RACE methods, iROAR is capable to make multiplex-PCR-based repertoires more consistent with RACE based ones.”</p><disp-quote content-type="editor-comment"><p>The authors very nicely showed the extent of amplification bias when using multiplex PCR based technologies by plotting the OAR distributions in Figure 2A and Figure 2B. It would be very informative to plot the iROAR corrected OAR and OAR distributions as well in order to visualise the improvement in bias correction in the same way.</p></disp-quote><p>Done. Figures 5 and 8.</p><disp-quote content-type="editor-comment"><p>The authors state that an F-test was performed to compare OAR distributions in Figure 2A. Please state exactly which F-test was used to calculate statistical significance.</p></disp-quote><p>We used nonparametric <italic>Levene's test</italic>. We specified it in the Figure 2 legend.</p><disp-quote content-type="editor-comment"><p>The authors state that they use a z-test to exclude outliers from the OAR calculation that may have resulted from large clonotypes introduced by PCR bias or naturally generated from clonal expansions. The authors should describe further how this affects analysis of repertoires in which large clonal expansions are expected such as during an antiviral immune response.</p></disp-quote><p>It’s just a simple mathematical issue due to the formula which we used for OAR calculation. The dramatic error in OAR calculation can occur only in the case of enormous lymphoproliferation far beyond normal antiviral immune response.</p><p>We corrected the related statement in the manuscript:</p><p>Also, the balance of V- and J-genes frequencies can be disrupted by accidentally arisen abnormally large non-functional clonotypes either artificially amplified due to the extreme PCR bias or naturally generated in the course of abnormal clonal expansion in various lymphoproliferative disorders or stochastic spike in normal lymphocyte population. To reduce the impact of this anomaly on OAR value, the top clone of each V and J-gene containing subgroups must be excluded from OAR calculation. Since V- and J-specific bias affects all clones non-selectively, the remaining large part of clones after top clones exclusion is still representative for PCR bias calculation. As shown in Figure 4A, the exclusion of one top clonotype from OAR calculation for RACE-based TRB repertoire is enough to restore OAR calculation accuracy for TRBV2, TRBV5-6, TRBV7-9, TRBV11-3. The further top clones exclusion has no significant effect on OAR values.</p><disp-quote content-type="editor-comment"><p>The authors nicely compared clonal frequency between iROAR corrected and 5'-RACE repertoires in Figure 4B-D. I think it would also be important to know how the iROAR algorithm would affect other measurements commonly used when analysing TCR/BCR repertoires. For example, does iROAR also affect measurements of diversity? This would be especially useful when comparing corrected repertoires vs. 5'-RACE.</p></disp-quote><p>By default, iROAR does not affect diversity since it does not remove any clones. This statement was added to the manuscript.</p><disp-quote content-type="editor-comment"><p>As per eLife policy, &quot;Regardless of whether authors use original data or are reusing data available from public repositories, they must provide program code, scripts for statistical packages, and other documentation sufficient to allow an informed researcher to precisely reproduce all published results.&quot; I would recommend that the authors very much improve the documentation provided in the Github repository for iROAR such that anyone can reproduce the published results before publication. Additionally, eLife suggests that the authors should license their code using an open source license.</p></disp-quote><p>We provided more detailed documentation of iROAR on GitHub and added step-by-step instructions in the Methods section. iROAR is totally free to the scientific community for non-profit usage.</p><disp-quote content-type="editor-comment"><p>Line 158: What do you mean by z-test? Can you explain under which circumstances you can decide to exclude abnormally large clonotypes? How has this threshold been calculated? Would this negatively affect measurements of OAR during an immune response such as viral infections where large clonotypes might be observed?</p></disp-quote><p>In the current version of iROAR we deleted z-test to improve calculation speed. However, we kept the option to discount the user-specified number of top non-functional clones (for each V and J gene) from the OAR calculation. It could significantly improve the accuracy of OAR calculation in case of strong clonal expansion, especially in lymphoproliferative disorders. To illustrate the impact of one top clone exclusion on OAR calculation improvement we added Figure 4a and the related text.</p><disp-quote content-type="editor-comment"><p>Line 167, 2.5 reads is a minimal sufficient sequencing coverage. Does the package provide this quality control check? This would be useful information that could be included in the manuscript as well as within iROAR documentation.</p></disp-quote><p>Done. This information is added to the iROAR report file.</p><disp-quote content-type="editor-comment"><p>Line 203 Figure 4: Can the authors also generate the OAR distributions (a per Figure 2B) for these datasets before and after iROAR? Would be very useful as a comparison between 5' RACE and other multiplex PCR methods as well as to assess the efficacy of iROAR in correcting bias.</p></disp-quote><p>Done. Figures 5 and 8.</p><disp-quote content-type="editor-comment"><p>Line 219, How does the in silico introduced bias look with regards to the OAR? Can you generate the OAR distributions of in silico biased and unbiased samples using the same graphing method in Figure2B?</p></disp-quote><p>Done. Figure 5.</p><disp-quote content-type="editor-comment"><p>The Discussion section needs much more discussion on its applications as well as limitations. Ie., how does the software deal with instances where clonal expansions occur in cell clones that are also bearing a non-functional receptor? How does this affect the OAR calculation?</p></disp-quote><p>To deal with this situation we recommend excluding the strongly expanded (top) non-functional clones from OAR calculation, as we mention above in responses as well as in the manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Enthusiasm is dampened by the fact that the proposed method is not directly compared to the gold standard of biological spike-ins. The results would be stronger if the authors could use data generated with a biological spike-in and compare correction using data from the spike-in versus their proposed algorithm. If such a data set is publicly available or can be obtained by request, this should be done. If such a data set cannot be obtained, then the Discussion section should directly address the fact that this gold standard validation remains to be done.</p></disp-quote><p>During manuscript revision, we designed and performed a wet-lab experiment to directly compare the iROAR approach with biological spike-ins.</p><disp-quote content-type="editor-comment"><p>Figure 2:</p><p>– More interpretation of the results is needed in the Discussion. For example, Figure 2a appears to show that for VMPlex and VJMPlex, most genes suffer from under- rather than over-amplification. This seems unexpected. I would have expected &quot;zero-sum-game&quot; behavior. Also, it is surprising that VJMPlex shows less overall bias than VMPlex. Does this make sense? Why or why not? I think a plot like Figure 1 is needed for VMPlex and VJMPlex to ensure that the base assumption underlying OAR calculation holds in the same way and to the same degree across the three technologies.</p></disp-quote><p>Thanks a lot for this observation. OAR coefficient is actually a relative measure. In the initial manuscript version, we used unnormalized OARs which can lead to misinterpretation of OAR values compared to other PCR bias measures. We corrected this inconvenience by using OAR normalized by average OAR value. This change can’t affect the bias removal process and at the same time will help to present bias coefficients in a more convenient way.</p><disp-quote content-type="editor-comment"><p>– Regarding the input data: &quot;for each method type 15 PBMC TCR repertoires were chosen randomly from&quot; and this is followed by a list of 11 study/project identifiers. More information is needed. Fifteen seems like a small number, but it depends on the details. How do the 11 studies distribute across the three methods? How many studies were included in each method? Were 15 repertoires total used for each method? Or 15 from each study? Did the different studies within a method use the same primer set? The same depth coverage?</p></disp-quote><p>Despite the number of published studies which used multiplex PCR-based methods for TCR profiling the number of publicly available raw read datasets is dramatically limited especially deep-sequenced ones. For this reason, the number of repertoires used for the analysis presented in Figure 2 was limited by available multiplex-based datasets (15 repertoires total for each method, i.e. 45 repertoires in sum, one repertoire for one individual). However, to address the concerns pointed out below we had to reduce this number to 6 repertoires per method. We corrected the figure legend according to the recommendation.</p><p>To equalize the sequencing coverage, we performed the down sampling as described in the Methods section.</p><disp-quote content-type="editor-comment"><p>– How much within-study between-repertoire variability is there for a single V or J gene? And how much variability is there across studies? It seems important to understand this basic behavior of the metric before pooling into a single figure, as the pooling can average out important behavior.</p></disp-quote><p>We corrected Figure 2 in order to show within-study between-repertoire variabilities.</p><disp-quote content-type="editor-comment"><p>Figure 3: More interpretation of the results is needed.</p><p>– In Figure 3a, the range of values is greater for TRBV and IGHV. Could this be attributed to a larger number of genes or primers, or to more sequence variability (and presumably therefore greater variability in primer hybridization efficiency)?</p></disp-quote><p>Thanks for the questions. We truly appreciate such attention to even small details of our research. The variability of IGHV’s OARs is smaller compared to multiplex PCR but a little bit greater than TCR’s OARs. Probably, it’s a consequence of differences between clonal dynamics of particular subsets of Т-cell and B-cell. We agreed, that it’s interesting phenomenon, it’s indeed needed to be investigated separately. But we can only speculate about it for now.</p><p>Added to manuscript:</p><p>“Herewith, the variance of IGHV’s OARs compared TCRs’ and the variance of TCR subpopulations' OARs compared PBMCs’ is slightly higher. This phenomenon may be linked to well-known differences in clonal expansion intensities of B/T-cell subsets. But the proof of this hypothesis demands separate deep analysis which is beyond the main focus of this research.”</p><disp-quote content-type="editor-comment"><p>– In Figure 3b, while there may be no difference in the mean or median OAR value across cell types, there does appear to be a difference in the range, with PBMCs and THs showing much less variability than the other cell types. What could explain this? Is this an artifact of the way samples were pooled for the figure? Are both donors represented in all six cell types? Or does this point to some interesting biology? If the latter, then exploration of this is understandably beyond the scope of this paper, but it should be mentioned and possible explanations should be put forward.</p></disp-quote><p>Added to manuscript:</p><p>“Herewith, the variance of IGHV’s OARs compared TCRs’ and the variance of TCR subpopulations' OARs compared PBMCs’ is slightly higher. This phenomenon may be linked to well-known differences in clonal expansion intensities of B/T-cell subsets. But the proof of this hypothesis demands separate deep analysis which is beyond the main focus of this research.”</p><disp-quote content-type="editor-comment"><p>Lines 197 – &quot;the procedure can be recursively repeated with a modified normalization coefficient defined as described coefficient raised to the power of a number in the range from 0 to 1.&quot;: How is the value of this number determined? This sounds like an optimization procedure, in which case much more information is needed. In particular: what algorithm was used? what is the objective function? What are the stopping criteria? In which of the presented results was this procedure applied?</p></disp-quote><p>The most quantitative bias can be corrected in the first iteration. (We added the corresponding sentence to the main text). All bias correction procedures in the manuscript were performed using a single iteration. But in terms of the flexibility of iROAR, we added an opportunity for the potential user to optimize the process of bias correction for their own multiplex system.</p><disp-quote content-type="editor-comment"><p>Line 87 &quot;constant during a lifetime&quot;: this needs to be substantiated with either a reference or data. The authors show relevant data in Supplementary Figure 1, but there is no description of how the data shown in the figure were derived. For example: are all data points from a single study? do all data points used in a single regression (i.e., all those corresponding to the same gene segment) derive from the same patient? do all data in the figure derive from one single patient? what sequencing protocol was used? Has the proposed correction been applied? The strength of the claim should reflect the strength of the data. Note: I don't think the truth of this claim is a requirement for the proposed method to be valid. So if the data are such that the statement cannot be generalized to &quot;all&quot; repertoires, I don't see this as a problem.</p></disp-quote><p>We agreed with Reviewer 2, that this part is quite irrelevant to this study and has to be analyzed in more detail, so we deleted the statement &quot;constant during a lifetime&quot; along with Supplementary Figure 1.</p><disp-quote content-type="editor-comment"><p>Line 89 &quot;reproducible&quot;: reproducible in what way? Over multiple aliquots of a sample? Over multiple samples for the same person? Over multiple people?</p></disp-quote><p>Reproducible in all these ways for each particular multiplex PCR primer system. The phrase “for the same multiplex PCR primer set” was added to the sentence.</p><disp-quote content-type="editor-comment"><p>Figure 1: Is the same stability observed for the sequencing protocols with even more amplification bias (VMPlex and VJMPlex)?</p></disp-quote><p>The point of the figure is that we show this stability on low-biased repertoires as a benchmark.</p><disp-quote content-type="editor-comment"><p>Lines 102 – 109: this paragraph is not clearly written, but it is the heart of the manuscript. The paragraph reads as if only the two terms with summations are based on out-of-frame rearrangements. I assume all four terms are based on out-of-frame rearrangements? Because otherwise the equation does not make sense …. Also, I recommend removing &quot;a percentage of&quot; in line 105, as this reads as if there is a percentage in the numerator of the numerator (i.e., the RC(Vi) term). Finally, in line 107, I assume you mean PCR amplification instead of clonal expansion?</p></disp-quote><p>Corrected</p><disp-quote content-type="editor-comment"><p>Figure 2: More information about the data is needed. Specific details are below.</p><p>Lines 149 – 153 starting with &quot;the average population frequencies&quot;: It isn't clear what is meant by &quot;average population frequencies&quot;, and it isn't clear what the rest of the paragraph implies about calculations described in the paper and results displayed in the figures. It sounds as if different repertoires may have been subjected to different calculations.</p></disp-quote><p>“Average population frequencies” was replaced by “population frequencies”. The usage of population frequencies is optional. The users may need it when they face repertoires obtained using multiplex PCR with extremely broad primer efficacies. Analysis in the main text was performed without this option. Since <italic>eLife</italic> rules do not allow Supplementary notes, we decided to not discard this section from the paper to show to potential users the way of overcoming this possible pitfall.</p><disp-quote content-type="editor-comment"><p>Lines 157 – 158: The last sentence of this paragraph suggests that V- or J-genes with large or small relative frequencies may have been excluded. More details are needed. Were only large clones excluded? How were they identified for exclusion? By what method and what exclusion threshold was used? How many were excluded from each repertoire? If more than &quot;a few&quot;, then before and after data need to be shown for some repertoires to show how this impacts the OAR distributions and averages.</p></disp-quote><p>In the current iROAR version user can define manually how many top non-functional clonotypes has to be excluded from OAR calculation. For most normal samples exclusion of one top clonotype for each V and each J-segment is sufficient to prevent inaccuracy in OAR calculation. To illustrate it we added suggested plots to Figure 4.</p><disp-quote content-type="editor-comment"><p>Lines 167 – 169: how is &quot;adequate&quot; defined? Within the 10% error range discussed in the context of Supplemental Figure 3?</p></disp-quote><p>Corrected:</p><p>“…adequate OAR values with the acceptable error rate of ~10%”.</p><disp-quote content-type="editor-comment"><p>Lines 257 – 262: These sentences suggest that the proposed approach is more reliable than biological spike-ins. This should be substantiated before being claimed. The authors state that this is because &quot;the impact of CDR3 structure&quot; is minimized. Why is this? Because the number of out-of-frame rearrangements is much much larger than the number of cell-line or synthetic spike-ins and so captures more CDR3 diversity? Or some other reason? More explanation of why this is being suggested should be given and the wording should make clear that this is an untested hypothesis.</p></disp-quote><p>We corrected the discussion sentence: “It makes this method potentially more reliable due to the ability to minimize the impact of CDR3 structure on PCR bias calculation since out-of-frame captures significantly higher CDR3 diversity”.</p></body></sub-article></article>